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ABSTRACT  
 
 
Vivien Ileana Maltez: Inflammasomes and cytotoxic lymphocytes clear bacteria from different 
intracellular niches 
(Under the direction of Edward A. Miao) 
 
 
Programmed cell death is a powerful anti-microbial defense. The innate immune system 
is our first line of defense against infection, and the induction of cell death can rapidly remove 
intracellular niches. Inflammasomes are multi-protein signaling complexes that result in 
pyroptosis, a form of lytic programmed cell death. However, a lack of strong in vivo 
inflammasome phenotypes has led to the conclusion that inflammasomes merely slow the 
infection until the adaptive immune system is activated. In Chapter 2, we report that 
inflammasomes provide penetrating and sterilizing immunity against two ubiquitous 
environmental bacteria, Chromobacterium violaceum and Burkholderia thailandensis. 
Additionally, the study of C. violaceum revealed the first evidence of natural killer (NK) cell 
cytotoxicity in defense against a bacterium in vivo. Thus, environmental microbes are powerful 
immunological probes and have great potential as model organisms. 
NK cells and cytotoxic T lymphocytes (CTLs) canonically induce apoptosis in target 
cells via granzyme B (a serine protease), which can directly cleave and activate caspase-3 and 
caspase-7. However, caspase-7 is often overlooked because, through the use of specific 
infectious models, it has been deemed dispensable for defense –an evolutionary relic. It is only 
expressed in specific tissues (such as the liver and gut) and has never been ascribed a unique and 
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specific role independent of caspase-3. In Chapter 3, we show that caspase-7 is uniquely required 
for defense against C. violaceum and Listeria monocytogenes. Caspase-3 could not compensate 
for the loss of caspase-7 in these models, and we demonstrate that caspase-7 activity is 
dependent upon perforin from either NK cells or CTLs. Furthermore, our results suggest a 
paradigm in which caspase-7 is preferentially required during bacterial, but not viral, infection. 
 
 
  
v 
 
 
 
 
 
 
To my friends and family, I could not have done it without you. 
  
vi 
 
 
 
ACKNOWLEDGEMENTS 
 
 I would like to thank Dr. Edward Miao for coming to his senses and taking me on as a 
graduate student. He has truly been a wonderful guide through my Ph.D. journey and has helped 
shape the scientist I am today with his indomitable high spirits and enthusiastic mentoring. I 
would also like to thank my lab members, past and present, who made daily lab life a fun and 
engaging experience. A special thanks to Alan Tubbs, who has been with me since the beginning 
of graduate school and with whom I began my initial thesis research. This work could not have 
been done without the amazing team of undergrads and lab manager, Ben McGlaughon, who 
somehow keep our ever-expanding mouse colony in order. I would also like to thank the 
Department of Microbiology and Immunology, for having such a welcoming, supportive, and 
involved faculty, staff, and students. I have been honored to call it home since my PREP year 
and will be sad to leave it behind.  
 Last, but not least, I would like to thank my husband, Miles. We began dating right 
before my qualifying exam, and somehow, he not only survived that experience, but stuck 
around for more! He has continued to be my biggest cheerleader, solid ground, and best 
companion throughout my journey – all my love and thanks.  
  
vii 
 
 
 
TABLE OF CONTENTS 
 
ABSTRACT ................................................................................................................................................. iii 
LIST OF ABBREVIATIONS ...................................................................................................................... ix 
CHAPTER 1: INTRODUCTION ................................................................................................................. 1 
THE INNATE IMMUNE SYSTEM: THE FIRST LINE OF DEFENSE ................................................ 1 
Pyroptosis: the end game for cytosolic defense .................................................................................... 2 
Naip Inflammasomes Give the Nod to Bacterial Ligands .................................................................... 4 
Bacterial models of inflammasome activation: wrought with caveats .................................................. 7 
INFLAMMASOME CROSSTALK TO CYTOTOXIC LYMPHOCYTES ............................................. 8 
Natural killer cells ................................................................................................................................. 9 
Cytotoxic T lymphocytes .................................................................................................................... 10 
The perforin cytotoxic pathway .......................................................................................................... 10 
REFERENCES ....................................................................................................................................... 12 
CHAPTER 2: INFLAMMASOMES COORDINATE PYROPTOSIS & NATURAL                       
KILLER CELL CYTOTOXICITY TO CLEAR INFECTION BY A UBIQUITOUS   
ENVIRONMENTAL BACTERIUM ......................................................................................................... 18 
SUMMARY ............................................................................................................................................ 18 
INTRODUCTION .................................................................................................................................. 19 
RESULTS ............................................................................................................................................... 21 
DISCUSSION ......................................................................................................................................... 29 
MATERIALS AND METHODS ............................................................................................................ 32 
FIGURES ................................................................................................................................................ 36 
REFERENCES ....................................................................................................................................... 45 
CHAPTER 3: CYTOTOXIC LYMPHOCYTES ACTIVATE CASPASE-7 IN TARGET                 
CELLS TO CLEAR BACTERIA ............................................................................................................... 49 
SUMMARY ............................................................................................................................................ 49 
INTRODUCTION .................................................................................................................................. 50 
viii 
RESULTS ............................................................................................................................................... 51 
DISCUSSION ......................................................................................................................................... 55 
MATERIALS AND METHODS ............................................................................................................ 57 
FIGURES ................................................................................................................................................ 63 
REFERENCES ....................................................................................................................................... 70 
CHAPTER 4: DISCUSSION ...................................................................................................................... 74 
PART I – Inflammasomes Defend Against the Purple Death ................................................................. 74 
PART II – Unique Roles for Caspase-7 in Bacterial Defense ................................................................ 86 
REFERENCES ....................................................................................................................................... 90 
ix 
LIST OF ABBREVIATIONS 
 
ROS  Reactive oxygen species 
NOS  Nitric oxide species 
CARD  Caspase activation and recruitment domain 
NOD  Nucelotide binding oligomerization domain 
NLR  NOD-like receptor 
LPS  Lippopolysaccharide 
PAMP  Pathogen associated molecular pattern 
DAMP  Damage associated molecular pattern 
T3SS  Type 3 secretion system 
IL  Interleukin 
NK  Natural killer cell 
TLR  TOLL-like receptor 
LRR  Leucine rich repeat 
APAF-1 Apoptotic protease activating factor 1 
IFN  Interferon 
CTL  Cytotoxic T lymphocyte 
TCR  T cell receptor 
 
  
1 
CHAPTER 1: INTRODUCTION 
 
The immune system has many mechanisms in place to defend the host, but one of the 
most crucial is programmed cell death. The work described herein will primarily focus on the 
importance of programmed cell death during bacterial infections. Although programmed cell 
death is vital for maintaining tissue homeostasis (1), it can also be used by both the innate and 
adaptive arms of the immune system to clear intracellular niches of pathogenic invaders (2). 
Indeed, many pathogens invade host cells to avoid extracellular defenses and gain easy access to 
nutrients. Programmed cell death is a means to counteract this subterfuge.  
 
 THE INNATE IMMUNE SYSTEM: THE FIRST LINE OF DEFENSE  
The immune system is generally thought to be divided both temporally and in 
composition into the innate and adaptive arms. The innate immune system reacts quickly to 
perceived injury or infection, and wanes after the first week. Some of the prominent innate 
defenders are macrophages, neutrophils, and natural killer (NK) cells. Macrophages and 
neutrophils phagocytose (eat) invaders and use antimicrobial arsenals, including reactive oxygen 
species (ROS) and nitric oxide species (NOS), to destroy the microbe (3). In contrast, natural 
killer cells, described in more detail in the section titled “Natural killer cells” below, hunt and 
destroy infected or otherwise compromised cells by extrinsically inducing cell death in the target 
(4).  
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 However, the innate immune system was historically considered to be of secondary 
importance to the adaptive immune system, since adaptive system immunodeficiencies have the 
most pronounced clinical symptoms (5). The adaptive immune system requires about a week to 
activate, but then frequently provides sterilizing and specific immunity. It is also responsible for 
forming the memory response that defends against repeated infection by the same pathogen (6). 
Much of the work described herein challenges the assumption that the innate immune system, 
particularly inflammasomes, merely holds the line until the adaptive immune system responds. 
 
Pyroptosis: the end game for cytosolic defense   
Inflammasomes are cytosolic sensors that detect microbial products or other cytosolic 
perturbations (7-9). The work described in this dissertation focuses on the canonical 
inflammasomes. These require a Nod-like receptor (NLR) protein, AIM2-like receptor (ALR) 
protein, or tripartite motif-containing (TRIM) protein, that will function as a signaling platform- 
integrating stimuli and leading to the activation of caspase-1 (13). Canonically, two signals are 
required for caspase-1 activation. Signal 1 is transcriptional priming of inflammasome 
components via toll-like receptor (TLR) stimulation, such as TLR4 by LPS. Signal 2 requires 
recognition of pathogen associated molecular patterns (PAMPs) or damage associated molecular 
patterns (DAMPs) by a specific inflammasome (14), such as AIM2 with dsDNA (15). The 
requirement for two signals to activate inflammasomes makes biological sense, as it puts the cell 
on yellow alert for potential invaders rather than immediately killing it.  
In fact, cell death is one of the primary outputs of caspase-1 activation. Caspase-1 will 
activate gasdermin D, leading to pore formation on the plasma membrane, cellular swelling, and 
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rapid lysis (16-18). Accordingly, this form of cell death is termed pyroptosis, which comes from 
two Greek words “pyro” and “ptosis” to describe its highly inflammatory nature (19). In 
addition, the inflammatory cytokines interleukin 1β and 18 (IL-1β and IL-18) are released via 
unclear mechanisms, though it has recently been proposed that gasdermin D is required (20). 
These cytokines signal to a variety of immune cells, notably neutrophils and NK cells (21).   
However, there is a prominent NLR that does not need a TLR signal one to activate: 
NLRC4 (22). This inflammasome will be critical to the work described in Chapter 2. NLRC4 
contains a caspase activation and recruitment domain (CARD) that can directly bind and activate 
caspase-1 (23). An example of 
NLRC4 activation is depicted in 
Figure 1.1, where microbial 
products, such as components of the 
type 3 secretion system (T3SS) or 
flagellin, are detected by adaptors 
(neuronal apoptosis inhibitory 
proteins - NAIPs) that then signal to 
NLRC4 (24-26). 
Below is a detailed structural description of how NLRC4 interacts with ligands. This 
section comes from a previously published Highlight article discussing the findings by Tenthorey 
et al (27).  
 
Figure 1.1. NLRC4 activation by microbial products 
and the downstream effects of caspase-1 activation.  
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Naip Inflammasomes Give the Nod to Bacterial Ligands1 
Our immune system must appropriately distinguish between friend and foe. To achieve 
this, immune cells are armed with toll-like receptors (TLRs) that survey the 
extracellular/vacuolar space, and NLRs that survey the cytosolic space. NLRs are defined by the 
presence of several subdomains (collectively the NACHT), including the nucleotide binding 
domain (NBD) and several discrete helical domains.  NLRs also typically contain an N-terminal 
signaling domain (such as a CARD) and C-terminal leucine rich repeat (LRR). Certain NLRs 
oligomerize to form inflammasomes that activate caspase-1, resulting in secretion of IL-1β/IL-18 
and pyroptosis (4). Assembly of the inflammasome is often paralleled to that of the apoptosome, 
which is an oligomer of the apoptotic protease factor 1 (APAF-1). The crystal structure of the 
apoptosome revealed a disk-shaped homo-heptamer, where a 40 amino acid structural motif  
terminating in a tryptophan-aspartic acid dipeptide (WD40, functionally parallel to the LRR 
domain) bind the APAF-1 ligand, cytochrome c (27, 28). Although the various activating ligands 
of NLRs are well characterized, the molecular basis for ligand recognition for most NLRs 
remains obscure (27, 29). Due to involvement of WD40 repeats in APAF-1 ligand binding, and 
the established role for the LRR of several plant NLRs and TLRs in ligand binding, many in the 
field expected the LRR domain to confer ligand specificity to mammalian NLRs (28, 30). 
However, in the study by Tenthory et al, they  map the ligand specificity domain of a subset of 
NLRs in the NAIP family to the α-helical domains within the NACHT, along with a short 
adjacent unannotated region (27). 
                                                           
1This chapter section contains a manuscript that previously appeared as an article in Trends in 
Immunology. This is the author's version of the work. The full citation is: Maltez, V.I. and Miao, 
E.A. “NAIP Inflammasome give the NOD to bacterial ligands.” Trends in Immunology, 35 
(2014) 503-504. doi:10.1016/j.it.2014.10.002 
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Amongst mammalian NLRs, the NAIPs are relatively unique in that they require another 
NLR, NLRC4, in order to activate caspase-1 (26, 31). Some plant NLRs have been shown to 
require “helper NB-LRRs” to fully potentiate immune signaling, analogous to the relationship 
between NAIPs and NLRC4 (32). Upon ligand binding, a trimeric complex including the ligand, 
NAIP, and NLRC4 forms (24, 31).  While mice are known to express NAIP1, NAIP2, NAIP5, 
and NAIP6, only one human NAIP has been identified. NAIP5 and 6 detect bacterial flagellin, 
NAIP2 detects the type III secretion system rod protein (including PrgJ), and mouse NAIP1 and 
human NAIP (hNAIP) detect the T3SS needle protein (24, 25, 33, 34). These proteins enter the 
host cytosol aberrantly via the T3SS, while the bacteria are actively secreting virulence factors to 
alter host functions (35). It is remarkable that despite the high degree of sequence identity 
between different NAIPs, they are highly specific for the ligands they recognize. Tenthorey et al. 
generated 43 NAIP2/5 and NAIP2/6 chimeras to rigorously map the ligand-sensing domain. 
They switched ligand specificity by swapping the α-helices and a short distal region. 
Remarkably, the LRR was not involved. 
There is ample evidence showing autoinhibition of NLRs by their LRR, for example, 
NLRC4ΔLRR constitutively oligomerizes (31). Additionally, recent crystal structures have 
revealed the LRR obscures the NBD when NLRC4 is in an inactive state (23). Thus, ligand 
binding to the helical domains must transmit a signal via conformational change to release the 
LRR from the NACHT, permitting oligomerization. This is a reasonable hypothesis to explain 
alleviation of autoinhibition within the NAIP; how this conformational change is accomplished 
within the NLRC4 monomer remains unknown. Perhaps when the NAIP binds its ligand, the 
three BIR domains are exposed, and these interact with NLRC4 to relieve autoinhibition. To add 
yet another twist, there is incomplete understanding surrounding the importance of 
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phosphorylated serine 533 on NLRC4, as some have shown it to be crucial for inflammasome 
activation (36), while others argue it is dispensable (37) or stabilizes autoinhibition of NLRC4 
(23).  
Tenthorey et al. further revealed that after ligand binding, the NAIPs do not oligomerize 
on their own. Instead they must recruit NLRC4 into a mixed oligomeric complex that can be 
observed in an average 5:2 ratio of NLRC4:NAIP, though other stoichiometries are possible, as 
11-fold symmetry has been previously proposed (38). Surprisingly, the NAIPs do not have to be 
the same, as NAIP5-flagellin and NAIP2-rod complexes can join into a single inflammasome 
with NLRC4 (Fig. 1.2a). The 
realization that ligand-bound 
NAIPs cannot oligomerize 
without NLRC4 is intriguing. 
It has been suggested that 
NAIP/NLRC4 
inflammasomes have disk-like 
symmetry, which could be 
indicative of an alternating 
pattern of ligand-bound NAIP 
and NLRC4 protomers. 
However it has been proposed 
that one ligand-bound NAIP is 
sufficient for NLRC4 oligomerization (38). Combined with the heterogeneous potential of 
NAIP/NLRC4 inflammasomes, this would suggest that 1 NAIP5-flagellin and 1 NAIP2-rod 
 
Figure 1.2. The APAF-1 apoptosome compared to the 
NAIP/NLRC4 inflammasome. The apoptosome is an oligomerization 
of APAF-1, which consists of 3 distinct domains, an N-terminal CARD 
(purple), an expanded nucleotide binding domain (blue), and WD40 
repeats (green) at the C-terminus. The WD40 repeats bind cytochrome c 
(red) and oligomerize to form a homo-heptamer, with each APAF-1 
bound to one cytochrome c. The NAIP/NLRC4 inflammasome can exist 
as a mixed oligomer. In a proposed heptamer formation, paralleling the 
apoptosome, different NAIPs (light blue) can bind their cognate ligand 
(rod-NAIP2, flagellin-NAIP5), recruiting NLRC4 (dark blue). This 
relieves autoinhbition by the LRR (green) and could twist the BIR 
domains (pink) for potential interactions with NLRC4. 
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complex would have the potential to recruit and activate 5 NLRC4 monomers to form a 
functional inflammasome. This may be a signal amplification mechanism. Consider that APAF-1 
requires 7 cytochrome c monomers to form the apoptosome (Fig. 1.2b). In contrast, if the 
NAIP/NLRC4 hetero-oligomer is also composed of 7 NLR monomers, it only requires only 1 
rod and 1 flagellin to oligomerize into an inflammasome. This could be particularly important for 
rod and needle detection, as these proteins are produced in vanishingly small quantities. Thus, 
the unique characteristics of the NAIP/NLRC4 oligomer could make it one of the most sensitive 
and rapid inflammasomes characterized so far. It remains to be seen whether other NLRs will 
follow the APAF-1 paradigm, or the NAIP model.  
 
Bacterial models of inflammasome activation: wrought with caveats   
The use of mouse models has revolutionized our understanding of how the immune 
system functions. Research into inflammasomes relies heavily on mouse models, yet the 
observed phenotypes are mild or incremental. In vivo, inflammasomes are dispensable or only 
mildly protective against model pathogens, such as Yersinia, Francisella, Listeria, Salmonella, 
and Shigella species (13, 25, 39-48). It is important to note that these pathogens are murine- and 
human-adapted, and therefore the phenotypes observed could arise for two distinct reasons: 
inflammasomes are truly not important for detection of these pathogens, or these pathogens have 
been selected or evolved in the presence of inflammasomes and thus established evasion 
strategies. Indeed, many have such evasion strategies to avoid inflammasome detection in vivo 
(Table 1.1). 
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Pathogen Cellular localization Possible 
detection 
Evasion 
strategy  
References 
Yersinia 
species 
Extracellular NLRP3 YopM (41) 
Francisella 
species 
Intracellular- 
cytosolic 
AIM2, 
caspase-11 
LPS 
modification 
(10) 
Listeria 
species 
Intracellular- 
cytosolic 
NLRC4 ↓ Flagellin  (40, 49) 
Salmonella 
species 
Intracellular- 
vacuolar 
NLRC4, 
AIM2 
 ↓ Flagellin, 
alternate T3SS 
(50) 
Shigella 
species 
Intracellular- 
cytosolic 
Caspase-11 OspC3 (51) 
Table 1.1. Host adapted pathogens evade inflammasome detection in vivo. 
However, in either case, it is challenging to understand why humans and mice have 
retained inflammasomes if they are truly ineffective and carry the risk of rapid death due to 
inflammasome-driven sepsis (8, 10). This suggested that there were undiscovered targets of 
inflammasome defense that might explain the retention of these potentially lethal intracellular 
sensors. We hypothesized that these targets could include environmental microbes that haven’t 
evolved in the presence of inflammasomes, and thus have not developed evasion strategies. This 
was the initial hypothesis that drove the work described in Chapter 2, which further led us to 
study the role of inflammasomes in coordinating other immune cells to clear intracellular niches; 
this will be introduced in the next section. 
 
INFLAMMASOME CROSSTALK TO CYTOTOXIC LYMPHOCYTES 
As described above, inflammasome activation leads to cytokine production. IL-18 was first 
discovered as a stimulator/inducer of interferon gamma (IFN-γ) (52), a pleiotropic cytokine that 
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increases the microbicidal activity of many cell types (53). The IL-18 receptor is highly 
expressed on natural killer cells and primes many of their cytotoxic effects (BioGPS) (54). In the 
work described in Chapter 2, we show the first example of NK cytotoxicity functioning against a 
bacterium in vivo. The work described in Chapter 3 directly arose from the findings in Chapter 2, 
and also heavily relies on the contributions of cytotoxic lymphocytes. As such, we will review 
two lymphocytic cell types, the natural killer cells and cytotoxic T lymphocytes. 
Natural killer cells  
The innate immune system employs natural killer (NK) cells to survey the host 
environment and defend against infected and cancerous cells. Although first discovered because 
of their “natural” ability to recognize and kill cancerous cells without additional priming (55), it 
has since been established that NK cells have memory-like properties with expansion and 
contraction phases upon re-stimulation with the same antigen (56, 57). Studies with NK cells 
have focused on viral and tumor models in vivo, as NK cytotoxic responses, described below in 
the “perforin cytotoxic pathway” section, have historically been dispensable against bacteria in 
vivo (58-62). 
The power of the NK response depends upon their ability to discern between 
infected/stressed/cancerous cells and healthy ones. They do this by recognizing the lack of MHC 
class I receptor (missing self) and/or by integrating the signals from activating and inhibitory 
receptors (4). NKG2D is the best characterized activating NK receptor, as its ligands are 
specifically upregulated in stressed or infected cells, but not healthy ones (63). However, the 
number and combinations of NK receptors is staggering (64, 65), making specific 
characterization of ligand-receptor interactions challenging. 
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Cytotoxic T lymphocytes  
The adaptive immune system also uses cytotoxic lymphocytes to target cells for 
destruction: cytotoxic T lymphocytes (CTLs). Analogous to NK cells, CTLs use the perforin 
pathway described below to induce cell death of target cells. However, they require T cell 
receptor (TCR) stimulation by dendritic cells or target cells that present cognate antigen in the 
context of self-MHC, unlike NK cells, and are thus highly specific for that antigen (66). They 
undergo massive clonal expansion to tackle the infectious or cancerous agent, and then contract, 
leaving a small memory pool behind to defend against repeat invaders (66).   
 It has been interesting that, prior to publication of the work in Chapter 2, NK cytotoxicity 
had not been shown against a bacterium, when it had been shown with the adaptive immune cell 
analogues: CTLs. Their cytotoxic activity has long been established to function against L. 
monocytogenes in vivo, and requires perforin (61, 67, 68). 
The perforin cytotoxic pathway  
 Despite the differences between NK cells and CTLs in recognition of their targets, both 
use the same weaponry to attack cells. Once in proximity to their target cell, NK cells and CTLs 
form an immunological synapse with target cells that traffics cytotoxic granules.  These granules 
contain a cocktail of deadly proteins, notably perforin and granzymes, intended to kill the target 
cell (69-71).  
Impressively, NK/CTLs regularly avoid self-intoxication with their toxic cargo. Perforin 
is a pore-forming protein that is highly dependent on pH and Ca2+ for activity; thus, perforin is 
stored in acidic granules and is only active at the neutral pH in the immunological synapse (72). 
Granzymes are potent serine proteases that, in the case of granzyme B, are capable of directly 
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cleaving and activating caspase-3 and -7, the apoptotic effector caspases (73). In order to defend 
against self-intoxication, CTLs express high levels of serpin B9, a granzyme B inhibitor (74). 
Together, these defense mechanisms protect NK/CTLs from their own killing capacity, enabling 
them to target infected/cancerous cells in the body.  
Conclusion 
The work described in Chapters 2-3 tackle the role of inflammasomes, NK cells, and 
CTLs in anti-bacterial defense. We believe our results demonstrate that inflammasomes are 
evolutionarily conserved not just to slow infections (discussed at length in Part I of Chapter 4), 
and that NK cells and CTLs use perforin and an underappreciated caspase to mediate anti-
bacterial defense in vivo (demonstrated in Chapter 3, discussed further in Part II of Chapter 4). 
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CHAPTER 2: INFLAMMASOMES COORDINATE PYROPTOSIS & NATURAL 
KILLER CELL CYTOTOXICITY TO CLEAR INFECTION BY A UBIQUITOUS 
ENVIRONMENTAL BACTERIUM2 
 
SUMMARY 
Defective neutrophils in patients with chronic granulomatous disease (CGD) cause 
susceptibility to extracellular and intracellular infections. As microbes must first be ejected from 
intracellular niches to expose them to neutrophil attack, we hypothesized that inflammasomes 
detect certain CGD pathogens upstream of neutrophil killing. Here, we identified one such 
ubiquitous environmental bacterium, Chromobacterium violaceum, whose extreme virulence was 
fully counteracted by the NLRC4 inflammasome. Caspase-1 protected via two parallel pathways 
that eliminated intracellular replication niches. Pyroptosis was the primary bacterial clearance 
mechanism in the spleen, but both pyroptosis and interleukin-18 (IL-18)-driven natural killer 
(NK) cell responses were required for liver defense. NK cells cleared hepatocyte replication 
niches via perforin-dependent cytotoxicity, whereas interferon-γ was not required. These insights 
suggested a therapeutic approach; exogenous IL-18 restored perforin-dependent cytotoxicity 
                                                           
2  This chapter contains a manuscript that previously appeared as an article in Immunity. I 
analyzed the data in all figures and co-wrote the manuscript with Dr. Miao. This is the author's 
version of the work. The definitive version was published in Immunity 43, 2015, 
doi:10.1016/j.immuni.2015.10.010. The full citation is: Maltez, V.I., Tubbs A.L., Cook, K.D., 
Aachoui, Y., Falcone, E.L., Holland, S.M., Whitmire, J.K, Miao, E.A. “Inflammasome 
coordinate pyroptosis and natural killer cell cytotoxicity to clear infection by a ubiquitous 
environmental bacterium.” Immunity (2015), vol 43 pp 987-997.  
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during infection by the inflammasome-evasive bacterium Listeria monocytogenes. Therefore, 
inflammasomes can trigger complementary programmed cell death mechanisms, directing 
sterilizing immunity against intracellular bacterial pathogens.  
INTRODUCTION 
Inflammasomes are innate immune sensors that detect cytosolic contaminations or 
perturbations. While canonical inflammasomes activate caspase-1, the noncanonical 
inflammasome pathway activates caspase-11. Caspase-1 processes interleukin-1β (IL-1β) and 
IL-18, leading to their secretion, and also triggers a form of programmed lytic cell death known 
as pyroptosis. The NLRC4 inflammasome responds to bacterial type III and IV secretion systems 
(T3SS and T4SS) by specifically detecting three conserved bacterial proteins when they are 
aberrantly translocated into the cytosol of host cells: flagellin, T3SS rod, and T3SS needle (1). 
Like most inflammasomes, NLRC4 must signal though the adaptor protein ASC to promote IL-
1β and IL-18 secretion. However, unlike the PYD-containing inflammasomes (including 
NLRP3, AIM2, and pyrin) it can also mediate pyroptosis directly via CARD-CARD domain 
interactions with caspase-1 (1). 
Inflammasome-deficient mice are more susceptible to a variety of pathogens, yet the 
defense conferred is typically only incremental. This was perhaps first and most thoroughly 
described for Salmonella typhimurium, which replicates somewhat faster in inflammasome-
deficient mice.  The overall effect on the infection is that inflammasome-competent mice die two 
days later than inflammasome-deficient mice (2, 3). Normalization of death kinetics can be 
accomplished by only a 4-fold change in the infectious dose (1, 4). Similar or lesser phenotypes 
are observed with Listeria monocytogenes, Yersinia pseudotuberculosis, Y. pestis, Francisella 
novicida, Mycobacterium tuberculosis, Klebsiella pneumoniae, Influenza, and Candida albicans 
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(1, 5-15). This has led to the conclusion that inflammasomes merely slow the infectious process, 
allowing the host to survive until an adaptive immune response clears the infection.  
Indeed, inflammasomes are ineffective in defense against systemic S. typhimurium and L. 
monocytogenes because these bacteria evade NLRC4, in part by repressing flagellin expression 
(1-3). We previously engineered S. typhimurium to express flagellin during systemic infection 
and found that it is completely attenuated in wild-type (WT) mice but remains fully virulent in 
inflammasome-deficient mice. We showed that pyroptosis ejects bacteria from intracellular 
replication niches, exposing them to attack by neutrophils, which kill the bacteria via reactive 
oxygen species (ROS) (16). The extreme efficiency by which the innate immune system 
eradicates evasion-deficient bacteria starkly contrasts with the typical role for inflammasomes in 
vivo as mechanisms to slow, but not halt, WT bacterial replication. We therefore hypothesized 
that there were naturally occurring environmental microbes that were analogous to engineered 
evasion-deficient bacteria. Such microbes would almost never cause disease in immune-
competent individuals because inflammasome detection results in completely penetrant innate 
immunity.  
Although caspase-1-deficient patients have not yet been identified, ROS-deficient 
patients are well studied. Chronic granulomatous disease (CGD) is caused by a variety of 
germline mutations in the genes for NADPH oxidase 2 (NOX2, encoded by Phox) that greatly 
reduce or eliminate ROS production in phagocytes (17). Patients with CGD are susceptible to 
infection by a characteristic array of not only extracellular, but also intracellular pathogens (18). 
In order for neutrophils to attack intracellular bacteria, these microbes must first be ejected from 
their intracellular niche. Thus, we hypothesized that a subset of CGD-associated pathogens are 
detected by inflammasomes and released from intracellular niches via pyroptosis. Herein we 
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identified one such bacterium, C. violaceum, and used it to reveal unappreciated inflammasome-
driven tissue-specific clearance mechanisms.   
RESULTS 
Inflammasomes prevent lethal infection by specific CGD pathogens  
We performed a survey of five CGD-specific bacteria in inflammasome-deficient mice. 
These were selected based on their inability to infect immunocompetent humans, and the 
bacterial species are further described in Extended Experimental Procedures.  
Burkholderia thailandensis is a ubiquitous soil bacterium that uses a T3SS to invade the 
cytosol, where it is detected by caspase-11 (4). Consistent with the hypothesis that caspase-11-
dependent pyroptosis exposes intracellular bacteria to killing by neutrophils, mice with the most 
common form of autosomal recessive CGD (Ncf1–/–, which encodes p47phox) were also 
susceptible to B. thailandensis infection, surviving slightly longer than Casp1–/–Casp11–/– mice 
while WT mice were fully resistant (Figure 2.1A-B). In contrast, species within the related 
Burkholderia cepacia complex (B. cepacia, B. cenocepacia, B. multivorans) that do not encode 
the T3SS were efficiently cleared by WT and Casp1–/–Casp11–/– mice, but were highly virulent 
in Ncf1–/– mice (Figure 2.1C and 2.2A-D). A similar result was observed for the CGD-tropic 
pathogens Francisella philomiragia (19, 20) and Serratia marcescens (18, 21) (Figure 2.1D and 
2.2C-F), illustrating that inflammasomes were not strictly required for defense against all CGD-
tropic pathogens.  
Chromobacterium violaceum is a Gram-negative bacterium that derives its name from the 
purple pigment that it produces, called violacin (22). C. violaceum is a ubiquitous environmental 
organism that inhabits aquatic environments in the tropics and subtropics (23). It encodes two 
T3SSs, Cpi-1 and Cpi-2, with similarity to the S. typhimurium SPI-1 and SPI-2 T3SS, 
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respectively (24, 25). Although the natural host that C. violaceum infects is unknown, the Cpi-1 
needle and rod proteins can be detected by the mammalian NLRC4 inflammasome in vitro (26, 
27). Most instances of C. violaceum infection in humans occur in immune compromised 
individuals, with 8.5% of cases occurring in confirmed CGD patients (28). C. violaceum 
infection in CGD patients is typified by rapid bacteremia often without a nidus of infection, and 
a 53% mortality rate (28). This is experimentally demonstrated in mice, where C. violaceum has 
minimal virulence for WT C57BL/6 mice, while it is highly virulent in Ncf1–/– mice (29) (Figure 
2.1E). We found that like Ncf1–/– mice, Casp1–/–Casp11–/– mice were acutely susceptible to C. 
violaceum infection. As few as 100 CFUs were lethal to Casp1–/–Casp11–/– mice, while WT mice 
survived a challenge of 1,000,000 CFUs (Figure 2.1E). This susceptibility was mirrored by high 
bacterial burdens in both the liver and spleen in comparison to WT mice, which cleared the 
infection (Figure 2.1F-I and 2.2G-J). The exquisite sensitivity of Casp1–/–Casp11–/– mice to C. 
violaceum represents the strongest effect of inflammasomes in defense against pathogens in the 
published literature, equaled only by their susceptibility to B. thailandensis (30). 
C. violaceum is liver-tropic in CGD patients (28). Upon examination of mice 3 days post 
infection with 100 CFU of C. violaceum, we observed numerous macroscopic lesions on the 
livers of Casp1–/–Casp11–/– mice (Figure 2.2K), associated with extensive neutrophil infiltration 
and a complete loss of structure around lesion foci in the liver (Figure 2.1J). These results 
revealed that certain environmental microbes, such as C. violaceum and B. thailandensis, had 
significant virulence potential that could not be contained in the absence of a coordinated action 
between inflammasomes and phagocyte-specific NADPH oxidase.  
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NLRC4 is required for protection against infection by C. violaceum in vivo 
The T3SS of C. violaceum can be detected by NLRC4 in vitro (26), but the role of 
NLRC4 during in vivo infection of C. violaceum has not been examined. Therefore, we next set 
out to determine whether the canonical inflammasome pathway (activating caspase-1) or the 
noncanonical inflammasome pathway (caspase-11) was more important for defense against C. 
violaceum. We found that caspase-11 was dispensable for defense, whereas Nlrc4–/–Asc–/– mice 
(which lack all canonical inflammasomes except NLRP1a/1b) remained highly susceptible to 
infection (Figure 2.3A). ASC is completely required for signaling by the PYD-containing 
inflammasomes, and for the cytokine outputs from NLRC4 (31). However, ASC is dispensable 
for NLRC4-driven pyroptosis (16). While ASC-deficient mice had an intermediate susceptibility, 
NLRC4 was absolutely required for resistance to infection (Figure 2.3B-F and 2.4A). These 
results suggest a role for pyroptosis and IL-1β and/or IL-18 in defense against C. violaceum.  
 
Differential role for pyroptosis against C. violaceum in the spleen and liver  
We next compared caspase-deficient mice to Il1b–/–Il18–/– mice to better understand the 
contributions of pyroptosis and cytokine secretion. Similar to the Asc–/– mice, Il1b–/–Il18–/– mice 
had an intermediate phenotype (Figure 2.5A-B), again consistent with roles for both pyroptosis 
and cytokines. Interestingly, we observed a different phenotype in the spleen, where Il1b–/–Il18–/– 
mice had few or no bacteria, like WT mice, while Casp1–/–Casp11–/– mice carried significant 
burdens (Figure 2.5C). This suggested that pyroptosis was the primary effector mechanism in the 
spleen, but that a more complex defense mechanism existed in the liver. 
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IL-18 is protective in the liver whereas IL-1β is dispensable 
IL-1β and IL-18 are pleiotropic cytokines that promote innate and adaptive immune 
responses. IL-1β is well known to induce fever, and to potentiate local inflammatory responses, 
resulting in neutrophil influx (32). IL-18 was first described as an interferon-γ (IFN-γ) 
stimulating cytokine, and IFN-γ responses are well established to promote defense against 
intracellular pathogens (33). In order to study the role of these cytokines in a more penetrant 
survival challenge, we increased the infectious dose to 104 CFUs, resulting in uniform lethality in 
Il1b–/–Il18–/– mice. At this dose, Il18–/– and Asc–/– mice were also highly susceptible to infection, 
while Il1b–/– mice were fully resistant (Figure 2.5D). In support of this, Asc–/–, Il18–/–, and Il1b–/–
Il18–/– mice all had elevated bacterial burdens in the liver, but not spleen, in comparison to WT 
and Il1b–/– mice (Figure 2.5E-F and 2.6A-B). These results further supported our hypothesis that 
pyroptosis was the primary defense mechanism against C. violaceum in the spleen, and revealed 
that IL-18, but not IL-1β, was protective in the liver.  
Natural killer cell cytotoxicity is required to clear intracellular replication niches  
In considering IL-18 responsive cell types, we found that NK cells have higher IL-18R 
expression than any other cell type or organ (Figure 2.7A). Accordingly, depletion of NK and 
NKT cells from WT mice resulted in elevated bacterial burden in the liver, but not the spleen 
(Figure 2.8A-B). As IL-18 secretion drives IFN-γ production in natural killer (NK) cells and 
certain T cells (34), and because IFN-γ is well established as a potent cytokine in defense against 
intracellular pathogens (33, 35, 36), we hypothesized that IFN-γ would be the primary effector 
mechanism downstream of IL-18. Surprisingly, this was not the case, as Ifng–/– mice had 
bacterial burdens comparable to those seen in WT mice (Figure 2.8C-D).  
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We then considered whether the predominance of IL-18 for liver but not splenic defense 
was in part due to the differences in cell populations between the liver and spleen. The spleen is 
primarily composed of macrophages, T cells, B cells, and dendritic cells. In contrast, 80-90% of 
the liver is composed of hepatocytes, with the remainder composed of Kupffer cells (liver 
resident macrophages), NK cells, and other immune cells (37). Thus, when considering target 
cells that C. violaceum may infect, the liver is dramatically different from the spleen. 
Interestingly, primary hepatocytes did not express detectable amounts of caspase-1 after LPS 
stimulation (Figure 2.8E). In contrast, splenocytes expressed abundant caspase-1 (Figure 2.8E), 
as do liver mononuclear cells (38). This may explain why pyroptosis appears to be sufficient to 
defend the spleen, but not the liver. Indeed, hepatocytes contained 90% of the C. violaceum 
bacterial burden in the liver (Figure 2.8F), and C. violaceum also efficiently infected primary 
hepatocytes in vitro (Figure 2.8G). However, consistent with the lack of caspase-1 expression, 
we did not observe appreciable lytic cell death in infected primary hepatocytes (Figure 2.8H and 
2.7D). In contrast, rapid and robust caspase-1/11-dependent lytic cell death was observed in liver 
immune cells and splenocytes (Figure 2.8H). Consequently, we hypothesized that a cell death 
pathway parallel to pyroptosis was required to eject the bacteria from their replicative niche in 
hepatocytes, and expose them to neutrophil killing.  
Previous studies show that exposure to IL-18 can prime the cytotoxic effects of NK and 
NKT cells in addition to promoting IFN-γ production (39, 40). These cytotoxic effects require 
perforin, a pore-forming protein that NK/NKT and cytotoxic T lymphocytes (CTLs) use to kill 
target cells (41, 42). However, while NK and/or NKT cell cytotoxic activity is a well-established 
antiviral effector mechanism (43), it has not been established as an important defense mechanism 
against intracellular bacteria. For example, WT and Prf1–/– mice had similar bacterial burdens 
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after infection with the model intracellular pathogens L. monocytogenes or S. typhimurium 
(Figure 2.8I-J and 2.7B-C). However, interpretation of these results were confounded by the fact 
that both L. monocytogenes and S. typhimurium largely evade NLRC4 in vivo (7, 16), thereby 
minimizing IL-18 secretion. Nevertheless, we examined whether perforin has a role in defense 
against C. violaceum, which was readily detected by NLRC4 in vivo. Both Prf1–/– and Casp1–/–
Casp11–/– mice had significantly higher bacterial burdens than WT and Ifng–/– mice in the liver, 
but again, only Casp1–/–Casp11–/– mice had substantial bacterial burdens in the spleen (Figure 
2.8K-L and 2.7E-F). These results indicated that NK and/or NKT cells were protective in the 
liver but were dispensable for splenic clearance (where pyroptosis was sufficient), and suggested 
that their cytotoxic activity as the primary protective mechanism.  
 
The adaptive immune system is dispensable for defense against C. violaceum  
Several cell types express perforin, including NK cells, NKT cells, and CTLs (41, 42). To 
determine whether NKT cells and/or CTLs, were required for resistance to C. violaceum, we 
examined Rag1–/– mice, which lack all B and T cells. Interestingly, Rag1–/– and WT mice had 
similar bacterial burdens and clearance kinetics (Figure 2.9A-B), demonstrating that neither 
NKT cells nor CTLs were the primary cytotoxic effector cells against C. violaceum infection. 
Additionally, we concluded that inflammasomes provided innate immunity against this 
ubiquitous environmental microbe that did not require an adaptive immune response. 
 
IL-18 administration improves NK cell recruitment and cytotoxicity in vivo 
We hypothesized that a lack of IL-18 in inflammasome-deficient mice prevented 
appropriate recruitment and/or stimulation of NK cells, so we examined whether administration 
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of exogenous IL-18 could restore NK cell function. IL-18 therapy resulted in significantly 
reduced bacterial burdens in Casp1–/–Casp11–/– and Il1b–/–Il18–/– mice (Figure 2.10A-B). 
However, because exogenous IL-18 did not fully normalize bacterial burdens in Il1b–/–Il18–/– 
mice, it was likely that IL-18 therapy could be further optimized from a pharmacologic 
standpoint. To examine the response of NK cells to IL-18, we performed flow cytometry on liver 
immune cells isolated from untreated and IL-18-treated Nlrc4–/–Asc–/– mice. IL-18 therapy 
promoted a three-fold increase in conventional NK cell numbers, but no increase of liver resident 
NK cells and NK1.1+CD3+ cell (likely NKT cells) numbers (Figure 2.10C-D and 2.11A). 
Granzyme B is a serine protease that is secreted from NK cells and CTLs along with perforin to 
mediate target cell death, and is an established marker for cyotolytic activation of these cell 
types. Notably, we saw increased granzyme B mean fluorescence intensity (MFI) in conventional 
NK cells, but no significant increase in the MFI of liver resident NK or NKT cells (Figure 2.10E 
and 2.11B). These results were consistent with the lack of phenotype in Rag1–/– mice (Figure 
2.9), and suggested that IL-18 was driving both NK cell recruitment to infected target organs and 
increased activation. 
Our model thus far suggested that pyroptosis was the primary defense mechanism in the 
spleen, while IL-18 drove defense in the liver. Thus, the observation that IL-18 treatment was 
therapeutic in the spleen of Casp1–/–Casp11–/– mice was unexpected (Figure 2.10B). However, 
Casp1–/–Casp11–/– mice are deficient for both pyroptosis and IL-18 in the spleen, therefore, 
pyroptosis and NK cytotoxicity could be independently sufficient to prevent bacterial 
colonization in the spleen. Unfortunately, pyroptosis-deficient mice have not been developed, so 
we cannot directly assess whether endogenous IL-18 would be sufficient in the absence of 
pyroptosis. 
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We next sought to provide evidence that IL-18 therapy acts through NK cells. Consistent 
with our findings, Nlrc4–/–Asc–/– mice were highly susceptible to C. violaceum infection, and 
bacterial clearance could be rescued by IL-18 therapy (Figure 2.10F). However, when 
simultaneously depleted of NK cells, IL-18 therapy failed. Further, IL-18 therapy also required 
cytotoxic activity, as Prf1–/– mice failed to respond (Figure 2.10G). Therefore, IL-18 acted 
upstream of NK cell cytotoxic activity against intracellular bacterial infection in vivo. 
 In order to demonstrate that C. violaceum infected hepatocytes can be killed by NK cells, 
we combined ex vivo and in vitro techniques. Hepatocytes were isolated from C. violaceum-
infected Ncf1–/– mice, which carried huge bacterial burdens in their liver. These were used as 
target cells for lysis by liver immune cells harvested from infected WT mice (Figure 2.10H). We 
observed hepatocyte killing that was ablated by NK cell depletion. Furthermore, hepatocyte 
killing increased with cells from IL-18 treated mice (Figure 2.10H). In summation, NK cells 
killed hepatocytes in vitro, and this killing was enhanced with IL-18 therapy, consistent with our 
in vivo results (Figure 2.10). 
Exogenous IL-18 is therapeutic against L. monocytogenes 
Our observations revealed a unique link between inflammasomes and NK cell 
cytotoxicity in defense against a ubiquitous intracellular environmental bacterium, so we sought 
to discover if this mechanism was applicable to a bona fide human pathogen. Like C. violaceum, 
L. monocytogenes is well established to infect hepatocytes (44). However, unlike C. violaceum, 
L. monocytogenes evades inflammasome detection. Therefore, we examined the efficacy of IL-
18 treatment during L. monocytogenes infection. Bacterial burdens were significantly decreased 
in the liver and spleen of IL-18 treated WT mice (Figure 2.12A-B), but there was no difference 
between untreated and treated Prf1–/– mice in the liver (Figure 2.12A). Splenic burdens were 
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decreased in Prf1–/– mice upon IL-18 therapy (Figure 2.12B), suggesting that there were also 
perforin-independent mechanisms of clearing the spleen, perhaps through IFN-γ. Importantly, 
despite the increased susceptibility of Ifng–/– mice to L. monocytogenes infection, IL-18 therapy 
was still beneficial to these mice (Figure 2.12C-D). Moreover, IL-18 therapy was still effective 
in Rag–/– mice, indicating that IL-18 acted independently of the adaptive immune system, as it 
did during C. violaceum infection (Figure 2.12E-F). Thus, perforin-dependent cytotoxicity 
against intracellular bacteria was a bona fide defense mechanism downstream of IL-18 secretion 
that was underappreciated due to the ability of many bacteria, such as L. monocytogenes, to 
driven tissue-specific clearance mechanisms.   
DISCUSSION 
While inflammasomes are appreciated to be an innate immune mechanism that slows the 
course of infection, prevailing published evidence indicates that inflammasomes ultimately fail 
to eradicate pathogens. However, studies using bacteria engineered to remove inflammasome 
evasion hint at the converse hypothesis: that inflammasomes have the unrealized capacity of 
directing sterilizing immunity (7, 16, 45). We propose that the importance of inflammasomes 
during infection is underappreciated because phenotypes have been interpreted in the face of 
confounding pathogenic evasion strategies. We further propose that animals are constantly 
exposed to a milieu of highly virulent environmental microbes that have remained 
uncharacterized because inflammasomes completely prevent disease in immunocompetent 
individuals. It is important to note that under our model, inflammasomes would be unimportant 
against environmental microbes that do not encode such potent virulence traits. 
Concordantly, C. violaceum and B. thailandensis are ubiquitous water and soil bacteria 
that rarely cause infection in humans, despite the fact that they encode potent virulence traits, 
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including T3SSs that enable intracellular replication or cytosolic invasion (28, 46). Our results 
herein show that inflammasomes detect these virulence traits, and initiate a specific innate 
immune defense program that provides sterilizing innate immunity. To our knowledge, the role 
of inflammasomes in defense against C. violaceum (shown here) and B. thailandensis (30) are 
the most penetrant inflammasome phenotype against any infection, be it bacterial, viral, fungal, 
or parasitic. We hypothesize that this is one example of a wide array of potentially lethal 
environmental microbes. Exposure to such microbes might exert a strong evolutionary pressure 
that could explain the maintenance and expansion of inflammasome genes. We propose that if 
people lacked NLRC4, swimming in freshwater lakes or streams might carry an incredible risk 
of death subsequent to infection by C. violaceum. 
 Why should we be interested in studying bacteria to which almost all people are innately 
immune? The answer lies in the fact that these bacteria offer us the opportunity to study the 
innate immune system in its fully functional state, unobscured by pathogenic evasion strategies. 
Our studies of C. violaceum reveal the importance of inflammasomes in driving parallel 
mechanisms to clear intracellular replication niches. Pyroptosis appears to be fully competent to 
protect the spleen, where inflammasome-expressing macrophages are abundant. This likely 
occurs in liver macrophages as well. It should be noted that we have not provided definitive 
evidence that pyroptosis is the mechanism of clearance in the spleen; our data address 4 of 7 
criteria that we have previously described (47). A rapid pyroptotic response in the early hours of 
infection is thus predicted to eliminate the bacteria before they can replicate to high numbers. In 
addition to pyroptosis, inflammasome-driven IL-18 primes NK cells to kill infected hepatocytes 
in the liver, providing an example where NK cell cytotoxicity is critical to bacterial clearance in 
vivo. 
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The two primary effector mechanisms used by NK cells are production of IFN-γ and 
cytotoxicity. NK cell cytotoxicity, a well-established mechanism against viral pathogens, is not 
established in defense against bacterial pathogens in vivo (33). There are numerous studies that 
demonstrate NK cell cytotoxicity in vitro against bacterially infected cells (33, 48), yet these 
responses were later found to be ineffective during infection in vivo (33, 49), likely because of 
pathogenic evasion strategies. We identified cytotoxicity, instead of IFN-γ, as the NK effector 
mechanism employed against C. violaceum infected hepatocytes in vivo. L. monocytogenes is 
also highly tropic for hepatocytes, yet NK cell cytotoxicity fails to clear this infection (44). We 
propose that this is due to inflammasome evasion strategies employed by L. monocytogenes in 
vivo, whereby IL-18 secretion is limited (7). Here we used IL-18 therapy as an innate immune 
booster to harness NK cytotoxicity and specifically eliminate L. monocytogenes-infected cells in 
the innate phase of infection.  
Therefore, when we study bona fide pathogens, it is difficult to distinguish between 
innate immune mechanisms that are simply not useful from those that are actively evaded. The 
latter could be harnessed therapeutically to combat the infection, and environmental bacteria like 
C. violaceum and B. thailandensis may be the key to uncovering such insights. We used the well-
studied susceptibility of CGD patients to identify extremely virulent bacteria that are normally 
cleared by the innate immune system with exquisite efficiency. It is likely that other 
environmental microbes, in a similar fashion, will inform our understanding of previously 
underappreciated innate immune clearance mechanisms. These microbes provide a lens with 
which to understand the capabilities of the innate immune system when it is correctly activated, 
acting as powerful tools to help develop therapeutics that bypass the evasion strategies of bona 
fide pathogens.  
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MATERIALS AND METHODS 
Bacterial strains and growth conditions 
The following strains were used in this work: C. violaceum (ATCC 12472), S. 
typhimurium (CS401), L. monocytogenes (10403s; kind gift from D.A.P.), and B. thailandensis 
(passaged through Casp1–/–Casp11–/– mouse strain). Additionally, the following strains were 
isolated from CGD patients (by S.M.H.): B. cepacia, B. multivorans, B. cenocepacia, F. 
philomiragia, and S. marcescens. 
S. typhimurium and all Burkholderia species were grown in Luria-Bertani medium (LB). 
C. violaceum, S. marcescens, and L. monocytogenes were grown in Brain heart infusion (BHI). 
F. philomiragia was grown in BHI + isovitalex. All strains were grown overnight at 37oC and 
back-diluted (1:40) for 2 hours for use in both in vitro and in vivo experiments. 
Mouse infections 
Mouse strain information and housing conditions are described in the Extended 
Experimental Procedures. For all mouse infections, 8-12 week old mice were infected with the 
designated colony forming units (Cfu) of log phase bacteria in PBS by intraperitoneal (IP) 
injection. Livers and spleens were harvested at the indicated time point (3, 4, 10, or 21 days post 
infection), homogenized and dilutions plated on LB or BHI as described above. For NK cell 
depletion, mice were injected IP with 75 μg anti-NK1.1 PK136 or isotype control C1.18.4 
(BioXCell) at -3 and -1 dpi. Depletion of NK1.1-positive cells was confirmed by flow cytometry. 
For IL-18 therapies, mice were injected IP with 0.2 μg recombinant mouse IL-18 (rmIL-18; 
MBL) at the time of infection, 24, and 48 hpi (C. violaceum infections), or 24, 48, and 72 hpi (L. 
monocytogenes infections).  
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Histology 
Livers and spleens were fixed in formalin and embedded in paraffin to generate section of 
5 μm thickness. Paraffin sections were counterstained with hemotoxylin and eosin. 
Cell isolation  
Livers were extracted, perfused with Collagenase D, put through a cell strainer (Falcon), 
and washed with DMEM. Cells were spun and the supernatant removed. Pellets were 
resuspended in 44% Percoll (GE Healthcare) in DMEM and under laid with 66% Percoll. Cells 
were spun at 2,000 x g and hepatocytes harvested from the upper layer. Lymphocytes were 
treated with RBC lysis buffer, spun, the supernatant removed, and the pellet resuspended in 
DMEM or 1X PBS depending on usage. Splenocytes were harvested in the same manner but 
without the Percoll gradient. Average hepatocyte purity as assessed by CD45 staining was 
determined to be 99.5%. Average liver immune cell purity as assessed visually by 
hemacytometer counting was determined to be >99.5%. 
Western blots 
For Western blots, total protein from lysates of 5 x 104 hepatocytes or splenocytes was 
analyzed. Caspase-1 expression was determined using an anti-caspase-1 antibody (clone 4B4, 
Genentech). Blots were stripped and equivalent loading of protein was ensured by Western blot 
using anti-β-actin HRP antibody (Cat. # 20272, AbCam) diluted 1:20,000.  
Bacterial count enumeration 
For percentages of intracellular C. violaceum in vivo, equal weights of livers were 
harvested. Total cfu were obtained from one section, cfu specific to the hepatocyte fraction from 
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the second section, and the hepatocyte cfu graphed as a percentage of the total. For percentages 
of intracellular C. violaceum in vitro, hepatocytes were isolated, seeded in a 96 well plate, and 
allowed to rest for 2 hours. C. violaceum were grown to log phase and hepatocytes were infected 
at an MOI of 25, with Gentamicin (5 ng/ml) added 30 min p.i. At various times post infection, 
intracellular bacterial burden was determined by plating.  
Flow cytometry 
For flow preparation, cells were Fc-blocked with anti-CD16/CD32 and stained with anti-
CD45-PercPCy5.5 (104), NK1.1-FITC (PK136), CD3, Granzyme B, and the cell viability 
marker Aqua dead live-AmCyan, all from BD. Cells were fixed in 2% PFA and samples were 
analyzed on a Becton Dickinson LRSIII (HTS) (UNC Flow Cytometry Core Facility). 
Assessment of NK killing in vitro 
Hepatocytes were harvested from Ncf1–/– mice 17 hpi with 100 Cv. Liver immune cells 
were harvested from WT mice under 3 conditions 48 hpi. (1-2) WT mice were treated with 
isotype or anti-NK1.1 antibody days 1 and 3 prior to infection with 104 Cv. (3) WT mice were 
infected with 104 Cv and treated with 0.2 μg rm IL-18 at the time of infection and 24 hours later. 
Hepatocytes and immune cells were seeded into 96 well plates and allowed to rest for 2 hours. 
Non-adherent immune cells were used to enrich for NK cells. The hepatocytes and immune cells 
were then coincubated at an effector: target ratio (E:T) of 50:1 and cell death was evaluated 6 
hours later. LDH release was defined as (LDHEXPERIMENTAL – LDHEFFECTORS – 
LDHSPONTANEOUS)/(LDHMAXIMAL – LDHSPONTANEOUS), where LDHEFFECTOR refers to the liver 
immune cells, LDHSPONTANEOUS refers to hepatocytes, and LDHMAXIMAL refers to total lysis of 
hepatocytes by Triton X-100. 
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Statistics 
Error bars represent the standard deviation of technical replicates. A standard two-tailed 
unpaired t-test (Prism 5; GraphPad) was used for statistical analysis, wherein P values of ≤ 0.05 
were considered significant.  
 
 
  
36 
FIGURES  
 
 
 
Figure 2.1. Inflammasomes and the NADPH oxidase are required to clear specific CGD 
pathogens. (A-D) Mice were infected IP with (A) 2x107 or (B) 1x104 cfu of B. thailandensis, 
(C) 1x106 cfu of B. cepcacia, (D) or 1x106 cfu of F. philomiragia and monitored for survival. 
Casp1–/–Casp11–/– mice referred to as Casp1-11DKO. Mice: (A) WT=9, Casp1-11DKO=10, Ncf1–/–
=10; (B) WT=4, Casp1-11DKO=6, Ncf1–/–=9; (C) n=4 for all; (D) n=5 for all. (E) Mice were 
infected IP with C. violaceum (Cv) at the indicated doses and monitored for survival. Mice: 
WT=4, Casp1-11DKO=7, Ncf1–/–=4. (F-I) Mice were infected IP with 100 cfu of Cv and bacterial 
burdens were measured in the liver and spleen (F-G) 72 hours later or (H-I) 17 hours later. (J) 
Mice were infected IP with 100 cfu of Cv and 72 hours later livers and spleens were embedded in 
paraffin and H&E stained. Data and statistical analyses are representative of at least two 
experiments (A-D, H-I), three experiments (F-G), or pooled from two experiments (E). Dashed 
line: limit of detection. * p ≤ 0.05; survival curve analysis (A-E), two-tailed unpaired t-test (F-I).  
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Figure 2.2. Not all CGD pathogens are cleared by inflammasomes. (A-B) Mice were infected 
IP with 106 cfu of B. cepacia or (E-F) 106 cfu F. philomiragia and bacterial burdens were 
measured in the liver and spleen 72 hours later. (C-D) Mice were infected IP with 106 cfu of B. 
cepacia, B. cenocepacia, B. multivorans, or S. marsescens and bacterial burdens were measured 
in the liver and spleen 21 days later. (G-J) Mice were infected with 103 cfu of C. violaceum (Cv) 
and bacterial burdens were measured in the liver and spleen (G-H) 10 days or (I-J) 21 days later. 
(K) Mice were infected IP with 100 cfu of Cv and images of livers taken 3 days post infection. 
Dashed line: limit of detection. All data and statistical analyses are representative of two 
experiments. * p ≤ 0.05; two-tailed unpaired t-test.  
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Figure 2.3. Canonical inflammasome signaling via NLRC4 prevents lethal infection by C. 
violaceum in vivo. (A-B) Mice were infected IP with 100 cfu of Cv and monitored for survival. 
Nlrc4–/–Asc–/– mice referred to as Nlrc4-AscDKO. Mice: (A) Casp1-11DKO=4, Nlrc4-AscDKO =4, 
Casp11–/– =5; (B) n=4 for all. (C-F) Mice were infected IP with 100 cfu of Cv, and bacterial 
burdens were measured in livers and spleens 72 hours later. All data and statistical analyses are 
representative of at least three experiments. * p ≤ 0.05; survival curve analysis (A-B) two-tailed 
unpaired t-test (C-F).  
 
Figure 2.4. Replicate experiment of NLRC4 and caspase-1/11 requirement for protection 
during C. violaceum infection. (A) Mice were infected IP with 100 cfu of Cv and monitored for 
survival. Mice: WT n=3, Casp1–/–Casp11–/– n= 4, Nlrc4–/– n= 4. Representative replicate 
experiment for Figure 2.3A-B. * p ≤ 0.05; survival curve analysis 
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Figure 2.5. Differential role for pyroptosis in the liver and spleen. (A and D) Mice were 
infected with Cv at the indicated doses and monitored for survival. Il1b–/–Il18–/– mice referred to 
as Il1b-Il18DKO. Mice: (A) Casp1-11DKO=5, Il1b-Il18DKO =7, Il1b–/– =5; (D) Il1b-Il18DKO =5, Il1b–
/– =5, Il18–/– =4, Asc–/– =5. (B-C and E-F) Mice were infected IP with 100 cfu of Cv and bacterial 
burdens were measured in livers and spleens 72 hours later. Data and statistical analyses are 
representative of at least two experiment (A and D-F) or three experiments (B-C), or pooled 
from two experiments (E-F). * p ≤ 0.05; survival curve analysis (A and D), two-tailed unpaired 
t-test (B-C and E-F). * over a line indicates that all data sets under the line have p ≤ 0.05 for 
each pair wise comparison possible.  
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Figure 2.6. IL-18 drives cytokine-mediated protection. (A-C) Mice were infected IP with 104 
cfu of Cv and monitored for survival (A) or bacterial burdens were measured in the liver and 
spleen 72 hours later (B-C). Mice: (A) WT n=3, Il1b–/– n= 5, Il18–/– n=4, Casp1–/–Casp11–/– n=3. 
(A) is a representative replicate experiment for Figure 3B. * p ≤ 0.05; survival curve analysis; 
two-tailed unpaired t-test (B-C). 
 
Figure 2.7. NK cells highly express IL-18 receptor components. (A) IL-18 receptor 
expression based on BioGPS data. (B-C) Mice were infected IP with 104 cfu of S. typhimurium 
or (E-F) 104 cfu of Cv and bacterial burdens were measured in the liver and spleen 72 hours 
later. (D) Primary hepatocytes were infected with Cv at an MOI of 25, treated with gentamicin 
30 minutes later, and cell death was determined at 1.5 hours and 8 hours post infection by LDH 
release. Data and statistical analyses are representative of two individual experiments. * p ≤ 0.05; 
two-tailed unpaired t-test (B-F).  
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Figure 2.8. Cytotoxic activity of NK cells is required for clearance of C. violaceum. (A-D 
and K-L) Mice were infected IP with Cv at the indicated doses and bacterial burdens were 
measured in livers and spleens 72 hours later. (A-B) Mice were injected IP with 75 μg of isotype 
or anti-NK1.1 antibody at 1 and 3 days prior to infection. (E) Primary hepatocytes and 
splenocytes from naïve WT mice were treated with LPS, lysed, and examined for caspase-1 via 
Western blot. (F) Mice were infected IP with 100 cfu of Cv and bacterial burdens were measured 
in livers 72 hours later. Equal weight liver sections were removed and the hepatocyte fraction 
was graphed as a percentage of the total burden by weight. (G) Primary hepatocytes were 
infected with Cv at an MOI of 25 and percentage of invasive bacteria was determined via 
gentamycin protection assay. (H) Primary hepatocytes, liver immune cells, and splenocytes were 
infected with Cv at an MOI of 10, treated with gentamycin, and LDH release was determined. (I-
J) Mice were infected IP with 103 cfu of L. monocytogenes (Lm) and bacterial burdens were 
measured in livers and spleens 72 hours later. Data and statistical analyses are representative of 
two experiments (C-D and I-J) or pooled from two (K-L) or three experiments (A-B). * p ≤ 
0.05; two-tailed unpaired t-test (A-D and I-L).  
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Figure 2.9. Adaptive immune responses are not required for sterilizing immunity against C. 
violaceum.  
(A-B) Mice were infected IP with 103 cfu of Cv and bacterial burdens were measured in livers 
and spleens at the indicated times. Data and statistical analyses are representative of two 
experiments. * p ≤ 0.05; two-tailed unpaired t-test.  
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Figure 2.10. Exogenous IL-18 recruits NK cells and primes their cytotoxic effects. (A-G) 
Mice were infected IP with 100 cfu of Cv and (A-B and F-G) bacterial burdens were measured 
in livers and spleens 72 hours later. (A-B and F) Mice were injected IP with PBS or recombinant 
mouse IL-18 (0.2 μg/dose at 0, 24, and 48 hours). (F) Mice were injected IP with 75 μg of 
isotype or anti-NK1.1 antibody at 1 and 3 days prior to infection. (C-E) Liver immune cells were 
collected and prepared for flow cytometry 1 day post infection. Markers for conventional NK 
(NK1.1hiDX5+), liver resident NK (NK1.1hi, DX5–), and (likely) NKT (NK1.1+DX5–CD3+) cell 
populations were determined in addition to granzyme B staining. (H) Hepatocytes were 
harvested from Ncf1–/– mice infected with 100 Cv 17 hpi. Liver immune cells were harvested 
from WT mice infected with 104 Cv under 3 conditions: isotype antibody treatment, anti-NK1.1 
antibody treatment, or IL-18 therapy. Cells were coincubated in a 96 well plate and hepatocyte 
killing was determined by LDH assay 6 hours later. A model of the experimental setup is 
provided. Data and statistical analyses are representative of at least two experiments (A-E, F), or 
pooled from two experiments (F). * p ≤ 0.05; two-tailed unpaired t-test (A-B and D-H).  
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Figure 2.11.  NK recruitment and cytotoxicity increase with IL-18 treatment. (A-B) 
Representative (A) CD3 staining or (B) granzyme B staining of NK1.1 populations 1 day post 
infection with 100 Cv with or without IL-18 therapy. 
 
Figure 2.12. L. monocytogenes burdens are reduced upon IL-18 administration. (A-F) Mice 
were infected IP with 103 cfu of Lm and injected IP with PBS or recombinant mouse IL-18 (24, 
48 and 72 hours), and bacterial burdens were measured in livers and spleens 4 days later. Data 
and statistical analyses are pooled from two experiments (A-F). * p ≤ 0.05; two-tailed unpaired t-
test (A-F).  
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CHAPTER 3: CYTOTOXIC LYMPHOCYTES ACTIVATE CASPASE-7 IN TARGET 
CELLS TO CLEAR BACTERIA3  
 
SUMMARY 
Bacteria often invade host cells to avoid extracellular immune defenses. This strategy can 
be counteracted by cytotoxic lymphocytes, such as natural killer (NK) cells and cytotoxic T 
lymphocytes (CTLs), which hunt down and execute host cells harboring intracellular pathogens 
(1, 2). NK cells and CTLs use perforin to deliver granzyme B, which cleaves and activates the 
executioner caspases (3). Among these, caspase-3 is considered to be the most critical, while the 
physiologic importance of caspase-7 has remained nebulous (4). Here, we find a unique role for 
caspase-7 that cannot be accomplished by caspase-3. We found that perforin attack by NK cells 
or CTLs against Chromobacterium violaceum or Listeria monocytogenes failed in caspase-7-
deficient mice. Adoptive transfer studies showed that NK cells or CTLs caused the activation of 
caspase-7 in infected hepatocytes. Conversely, perforin attack by NK cells or CTLs against 
murine cytomegalovirus or lymphocytic choriomeningitis virus was unimpaired in caspase-7-
deficient mice. These results suggest a paradigm in which caspase-7 is required for clearance of 
intracellular bacteria, but not viruses. 
                                                           
3 This chapter contains a manuscript in submission. This is the author’s version of the work. The 
current authors, in order: Maltez, V.I., Mitchell, J.E., Tubbs, A.L., Rayamajhi, M., Nash, W.T., 
Brown, M.G., Whitmire, J.K., and Miao, E.A.  
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INTRODUCTION  
 
The work described in Chapter 2 directly led us to further investigate the NK-perforin 
pathway, due to its unique role against C. violaceum. Although the previous chapter primarily 
focused on inflammasomes and pyroptosis, this chapter will primarily focus on the role of 
apoptotic caspases in programmed cell death.  
 Apoptosis is not only required for tissue homeostasis, but is frequently the type of cell 
death induced by the cytotoxic cells of the immune system, NK cells and CTLs (5). Canonically, 
apoptosis is driven by the sequential activation of an initiator caspase (caspase-2, -8, or -9) and 
then an executioner caspase (caspase-3, -6, or -7) (4, 6). Importantly, NK cells and CTLs can 
bypass the initiator caspase step, leading to direct cleavage and activation of the executioner 
caspases. This occurs via perforin-mediated delivery of granules containing granzymes to the 
target cell (7). In particular, granzyme B can directly cleave and activate both caspase-3 and -7, 
initiating apoptosis of the target (3, 8). In contrast to pyroptosis, apoptosis is generally an 
immunologically silent form of cell death that is meant to minimize damage to bystander cells 
and keep excessive inflammation to a minimum (2).   
NK cells use perforin-mediated cytotoxicity to attack virally infected cells and tumors. In 
contrast, in vitro examples of NK cytotoxicity against bacteria consistently failed to translate to 
in vivo experiments until our recent findings with C. violaceum (9-14). C. violaceum is a 
ubiquitous environmental bacterium that only infects immunocompromised individuals. It infects 
the spleen where it is detected by inflammasomes, multi-protein signaling complexes that enable 
the infected cells to kill themselves via pyroptosis, while simultaneously maturing and releasing 
the cytokines IL-1β and IL-18 (as described in Chapter 2). C. violaceum also infects the liver, 
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where hepatocytes lack inflammasome components and thus are unable to kill themselves during 
infection. This problem is rectified when inflammasome-driven IL-18 primes NK cytotoxicity 
(14). We here investigate the outcome(s) of perforin-mediated cytotoxicity on infected 
hepatocytes, using both bacterial and viral models to probe the unique roles of apoptotic caspases 
in this pathway. 
RESULTS  
 
NK cells identify possible targets by integrating signals from inhibitory and stimulatory 
receptors, of which NKG2D is the most prominent stimulatory receptor (15). However, mice 
lacking the NKG2D receptor (Klrk1–/–) remained resistant to C. violaceum, whereas Prf1–/– 
controls have increased liver burdens (Fig. 3.1a), suggesting that other NK receptors compensate 
for the loss of NKG2D. Thus, we turned our focus to the downstream effects of perforin on 
target cells. 
Perforin delivers granzymes to target cells, most prominently granzyme B, which 
activates caspases to induce apoptosis (7, 16, 17). There are three apoptotic executioner caspases: 
caspase-3, -6, and -7. Caspase-3 is considered the primary executioner, as it is responsible for the 
vast majority of protein cleavage events during apoptosis (18). Since neither caspase-7 nor 
caspase-6 can typically compensate for the loss of caspase-3 in cleaving the majority of apoptotic 
substrates (6), they have held less prominent roles in the field. However, we examined potential 
roles for all the executioner caspases in defense against C. violaceum. Casp6–/– mice showed no 
increased susceptibility to C. violaceum (Fig. 3.1b). Surprisingly, we found that Casp3–/– mice 
were aberrantly hyper-resistant to infection (Fig. 3.1c). Casp3–/– mice are known to have 
elevated serum type I IFN in the absence of infection (19); as an NK-stimulating cytokine, type I 
IFN may cause the NK response to occur more rapidly. In contrast, Casp7–/– mice were 
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susceptible to C. violaceum infection with liver burdens that were equal to Prf1–/– mice (Fig. 
3.1d), suggesting that perforin and caspase-7 functioned in a linear pathway. These data indicate 
that neither caspase-3 nor caspase-6 can compensate for the loss of caspase-7 in defense against 
C. violaceum infection.  
We hypothesized that caspase-7 functioned within the hepatocyte compartment and 
downstream of NK cell perforin activity. The relative position of IL-18 in this pathway can be 
determined via IL-18 therapy – inflammasome-deficient mice were rescued by treatment with the 
downstream cytokine IL-18 (Fig. 3.1e). In contrast, Casp7–/– mice failed to respond (Fig. 3.1e). 
The position of NK cells in this pathway can be determined via an adoptive transfer model – 
WT, but not Prf1–/–, NK cells rectified the bacterial clearance defect in Prf1–/– mice (Fig. 3.1f 
and Fig. 3.2a). However, NK cell transfer failed to reduce burdens in Casp7–/– mice (Fig. 3.1g). 
As expected from our previous work, the perforin and caspase-7 phenotypes were specific to the 
liver, as splenic defense was not compromised in Prf1–/– or Casp7–/– mice (Fig. 3.2b-f), 
consistent with our previous conclusion that inflammasome-driven pyroptosis is sufficient to 
clear the splenic niche (14). These data suggest that caspase-7 acts downstream of both IL-18 
and NK perforin activity. 
In order to definitively assign caspase-7 to hepatocytes, we used an antibody that only 
recognizes the active (cleaved) form of caspase-7. C. violaceum liver infection results in 
macroscopic 3-4 mm lesions (14) that were easily detected by immunofluorescence. 
Inflammasome-deficient mice had large lesions with no appreciable cleaved caspase-7 signal 
(Fig. 3.3a). In contrast, treatment of these mice with IL-18 resulted in robust cleaved caspase-7 
signal in cells that ringed the lesion (Fig. 3.3b-g). The cleaved caspase-7 signal was specifically 
localized to the hepatocytes, which were identified by staining for CPS1 (20) (Fig. 3.3c, d, h).  
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We next moved to another model where NK cell perforin-cytotoxicity can be activated 
therapeutically to clear a different bacterium. Like C. violaceum, L. monocytogenes also infects 
hepatocytes. However, L. monocytogenes evades the inflammasome response in vivo (21, 22), 
limiting IL-18 signaling to avoid priming the host NK cell response. The NK response can be 
restored by IL-18 therapy in WT mice, but this fails in both Prf1–/– mice (14) as well as NK-
depleted mice (Fig. 3.3i). Like C. violaceum, NK cell defense against L. monocytogenes was 
independent of NKG2D (Fig. 3.3j). More importantly, IL-18 priming of this NK cytotoxicity 
failed to clear L. monocytogenes in Casp7–/– mice (Fig. 3.3k). Therefore, IL-18 primes NK cell 
cytotoxicity to clear two different bacteria in a caspase-7-dependent manner. 
 While L. monocytogenes naturally evades NK cytotoxicity, it is efficiently identified and 
eradicated by the CTL response (23). Accordingly, we hypothesized that caspase-7 would be 
essential downstream of CTL cytotoxicity against L. monocytogenes (this is typically 
demonstrated via adoptive transfer models (12, 24); Fig. 3.4a and Fig. 3.5). First, as a negative 
control, WT and Casp7–/–  mice had comparable burdens when transferred with naïve CTLs (Fig. 
3.4b, Naïve). However, transfer of CTLs from ∆actA L. monocytogenes-vaccinated mice 
(Immune CTLs) successfully reduced burdens in WT mice, but were significantly defective in 
Casp7–/– recipients (Fig. 3.4b, Immune). Further, CTLs from vaccinated Casp7–/–  mice 
successfully reduced burdens in WT recipients, while CTLs from vaccinated Prf1–/– mice were 
defective (Fig. 3.4c), indicating that caspase-7 was not acting within the CTLs themselves. 
Reciprocal transfers between Prf1–/– and Casp7–/– mice reinforce this conclusion (Fig. 3.4d).  
Interestingly, the CTL response was different in the spleen, where neither perforin nor 
caspase-7 were required (Fig. 3.6). It is likely that the primary niche in the spleen are 
macrophages, which should clear their infection via CTL-elaborated IFN-γ. These data revealed 
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a CTL–perforin–caspase-7 defense axis that was uniquely required in the liver during L. 
monocytogenes infection. 
Previous reports have shown that caspase-1, which mediates the programmed cell death 
termed pyroptosis, can directly cleave and activate caspase-7 (1). However, we have previously 
found that caspase-1 is not expressed in hepatocytes (14). Consistent with this, CTLs functioned 
in Casp1–/–Casp11–/– mice, but not Casp7–/– mice (Fig. 3.4e). Similarly, IL-18 treatment during 
C. violaceum infection is therapeutic in Casp1–/–Casp11–/– mice, driving the activation of 
caspase-7 in the absence of caspase-1 (Fig. 3.3a-g). This is consistent with the established ability 
of granzyme B to activate caspase-7 in these infectious models (7, 16, 17).  
The data above indicates caspase-7 functions in the recipient compartment, where L. 
monocytogenes primarily infects hepatocytes (Fig. 3.7a). Accordingly, hepatocytes from L. 
monocytogenes-infected livers contained a significantly increased number of cleaved caspase-7 
positive cells (Fig. 3.8a-b), commensurate with the expected prevalence of infected cells in the 
tissue (Fig. 3.7a). L. monocytogenes infection leads to easily identifiable inflammatory foci in 
tissue sections of the liver. As we saw with C. violaceum, the periphery of these inflammatory 
foci readily stained for cleaved caspase-7, but only when immune CTLs were transferred into the 
mice (Fig. 3.8c-e). Again, this cleavage was localized to hepatocytes (Fig. 3.8f-g). Finally, 
cleaved caspase-7 positive cells harbored visible L. monocytogenes (Fig. 3.8h-i). These data 
demonstrate that L. monocytogenes-infected hepatocytes are attacked by CTLs, which activate 
caspase-7, leading to bacterial clearance. 
CTLs are adept at attacking not only L. monocytogenes, but also virally infected cells. 
Lymphocytic choriomeningitis virus (LCMV; Armstrong strain) can infect hepatocytes (24) (Fig. 
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3.7b) and results in acute infection that is cleared by the CTL perforin response (25, 26). As 
expected, Prf1–/– mice had a clearance defect compared to WT mice (Fig. 3.8j), but we observed 
that Casp7–/– mice remained fully resistant (Fig. 3.8j). Finally, to provide a viral paralog to our 
study of C. violaceum and NK cells, we next examined murine cytomegalovirus (MCMV) as it is 
a prominent pathogen targeted by the NK cytotoxic response  and infects hepatocytes in vivo 
(27). As expected, Prf1–/– mice were susceptible to MCMV, but in contrast, Casp7–/– mice had 
normal resistance (Fig. 3.8k). Therefore, neither CTL attack against LCMV, nor NK cell attack 
against MCMV required caspase-7.  
 
DISCUSSION  
 
A pivotal in vivo role for caspase-7 in cell death has been elusive, with sometimes 
conflicting reports (28, 29). In the absence of strong and reproducible phenotypes in Casp7–/– 
mice, the prevailing opinion had been that caspase-7 is an inefficient substitute for caspase-3. For 
example, the embryonic lethality of Casp3–/– mice is rescued by caspase-7 only on the C57BL/6 
background (4), and not the 129/Sv background (30). This leads to the conclusion that caspase-7 
is a poor substitute for caspase-3 that only functions in oddly specific genotypes. Here, we 
examined the in vivo roles for caspase-7 in defense against multiple infectious models, where 
NK cells and CTLs use perforin-mediated cytotoxicity to eliminate infected cells.  
Despite the prevailing opinion that caspase-7 is merely a redundant substitute for 
caspase-3, previous studies have suggested that caspase-3 and caspase-7 could perform unique 
functions during apoptosis (18, 31). In fact, it has been posited that caspase-7 could be required 
for appropriate cell detachment during cell death (31). We hypothesize that we are indeed 
observing cell detachment in cleaved caspase-7 positive cells by immunofluorescence (Fig. 3.3 
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and 3.8), which could serve two functions. First, cell detachment could aid in a process by which 
cellular debris is engulfed and destroyed by professional phagocytes (efferocytosis) (32), which 
maintains tissue homeostasis and kills bacteria trapped within the cell corpse (33). Second, 
alternatively, or in conjunction with, cell detachment could inhibit the cell–to–cell spread used 
by many pathogens. L. monocytogenes is a prime example of this, as it uses actin rockets to 
travel between cells (34). Both of these possible functions for caspase-7 activation could also 
explain why caspase-7 was not required against MCMV nor LCMV. Apoptosis alone will halt 
viral replication (35), minimizing the need for efferocytosis to kill the invader. Additionally, 
viruses can spread via a variety of mechanisms, some of which do not require contact between 
cells (36), minimizing the impact of cell detachment on viral spread. It will be interesting to see 
whether future studies can differentiate between these hypotheses.  
In conclusion, our study reveals an essential role for caspase-7 against C. violaceum and 
L. monocytogenes that is dependent upon the perforin cytotoxic pathway used by NK cells and 
CTLs. Caspase-3 cannot compensate for the loss of caspase-7, indicating a dominant and 
penetrant role for caspase-7–mediated defense in our models. Remarkably, despite initiation of 
cell death by the same cytotoxic lymphocytes, clearance of two bacteria, but not two viruses, 
required caspase-7 in the target cells. Caspase-7, not caspase-3, was the dominant and essential 
executioner downstream of perforin activity against these bacteria. Therefore, we may have 
established a paradigm where caspase-7 is important against intracellular bacteria but not 
viruses. 
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MATERIALS AND METHODS 
Strains and growth conditions 
Bacterial strains used in this work: C. violaceum (ATCC 12472), L. monocytogenes 
(10403s derivative, native inlAB replaced with mouse-specific inlAmB, PMC 2869327), and L. 
monocytogenes ∆actA mutant (kind gift from the lab of D.A.P.). C. violaceum, L. 
monocytogenes, and L. monocytogenes ∆actA were grown in Brain heart infusion (BHI). 
Bacterial strains were grown overnight at 37oC and back-diluted (1:40) for 2 hours for all 
experiments.  
Viral stocks of lymphocytic choriomeningitis virus (LCMV) were generated from 
infected BHK-21 monolayers (lab of J.K.W.). Viral stocks of murine cytomegalovirus (MCMV, 
Smith Strain, ATCC #VR-1399) were grown in 3T12 cells (ATCC), passaged in weanling 
BALB/c mice, harvested from salivary glands and quantified in viral plaque assays (37)(kind gift 
from the lab of M.G.B).  
Mouse infections 
Mice were housed in a pathogen-specific free facility: wild type (WT) C57BL/6 (Jackson 
Laboratory), Prf1–/– (Jackson #002407), Casp7–/– (Jackson #006237), Casp3–/– (Jackson 
#006233), Nlrc4–/–, Casp1–/–Casp11129mt/129mt referred to as Casp1–/–Casp11–/–[REF (38)]. All 
animal protocols were approved by the Institutional Animal Care and Use Committee at the 
University of North Carolina at Chapel Hill and met guidelines of the US National Institutes of 
Health for the humane care of animals. For all mouse infections, 8-12-week-old mice were 
infected with the designated colony forming units (cfu) or plaque forming units (pfu). C. 
violaceum and MCMV were delivered in PBS by intraperitoneal (IP) injection; L. 
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monocytogenes was delivered in PBS by intravenous (IV) injection; LCMV was delivered in 
DMEM by IP injection. For NK cell depletion, mice were injected IP with 100 μg anti-NK1.1 
PK136 or isotype control C1.18.4 (BioXCell). Depletion of NK1.1-positive cells was confirmed 
by flow cytometry. For IL-18 therapies, mice were injected IP with 0.2 μg recombinant mouse 
IL-18 (rmIL-18; MBL) at the time of infection, 24, and 48 hpi as we previously described (14). 
For bacterial and viral enumeration, organs were bead homogenized and serially diluted on BHI 
agar plates (C. violaceum and L. monocytogenes) or for plaque/TCID50 assays (LCMV and 
MCMV). 
Cell isolation  
Hepatocytes were isolated based on previous reports (39). Livers were extracted, 
perfused with collagenase type I, incubated for 10 minutes at 37oC with CO2, mashed through a 
cell strainer (Falcon), and washed with RPMI. Cells were spun at 3 times at 50 x g for 5 minutes 
in 15 ml of RPMI. Hepatocytes were resuspended once in PBS and spun again as before. They 
were then treated with RBC lysis buffer, spun, and the pellet resuspended in RPMI or 1X PBS 
depending on usage. For splenocyte isolation: spleens were mashed through a cell strainer and 
washed with RPMI. Cells were spun at 1,000 x g for 5 minutes, once in RPMI, and once in PBS. 
They were then RBC lysis treated, spun, and the pellet resuspended in RPMI or 1 X PBS.  
Adoptive transfer of natural killer cells 
Splenocytes were harvested from naïve mice as described above. Cells were seeded into 
10 cm non TC-treated dishes with RPMI + 10% FBS + NEAA + Pen/Strep + 15 ng/ml IL-2. 
Four days later, the supernatant was removed and spun at 1000 rpm for 5 minutes to remove 
dead cells. The supernatant was returned to the dish along with 2 ml of new media with an 
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additional 10 ng/ml of IL-2. Six days post initial plating the cells were counted and used for 
transfer. Representative flow validation of NK purity is in Fig, 3.2. 
Adoptive transfer with bacterial count enumeration 
For experiments using bacterial counts from L. monocytogenes infections, donor mice 
were vaccinated with 1x106 of the L. monocytogenes ∆actA mutant strain or mock injected with 
PBS as described previously(24). NK cells were depleted in all donor mice on day 5 post 
challenge to remove potential confounding NK contributions. Splenocytes were harvested from 
naïve or immunized mice as described above. Recipient mice were then adoptively transferred 
via IV injection with 5x107 bulk splenocytes (representative data in Extended Data Fig. 2). One 
hour post AT recipient mice were IV injected with 5x104 cfu of L. monocytogenes. Mice were 
harvested 3 days later with livers and spleens homogenized and dilutions plated on BHI. 
Adoptive transfer with flow and immunofluorescence analysis 
For experiments examining cleaved caspase-7 expression (Figure 4) in L. monocytogenes 
infections, donor mice were vaccinated, NK depleted, and splenocytes harvested as in the AT 
experiments described above. Recipient mice were IV injected with 5x104 L. monocytogenes 2 
days prior to AT. Recipient mice were then transferred with 8x107 bulk splenocytes via IV 
injection. Mice were harvested 24 hours post AT. One lobe of the liver was prepared for 
immunofluorescence, and hepatocytes isolated from the remaining liver lobes for flow 
cytometry. 
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Flow cytometry 
Surface and intracellular staining was performed directly ex vivo. Cells were Fc-blocked 
with anti-CD16/CD32 and surface stained with anti-CD45-PercPCy5.5 (104), NK1.1-FITC 
(PK136), and CD8 (Biolegend #109807). Cells were fixed in 2% PFA either overnight at 4oC or 
for 20 minutes on ice before permeabilizing with 10X Fix/Perm Buffer (Biolegend #421002) on 
ice. Cells were incubated with cleaved capase-7 antibody (Cell Signaling #9491, 1:500, 45 
minutes) followed by APC-conjugated secondary anti-rabbit antibody (Cell Signaling, #4414s, 
1:1000, 45 minutes). After 5 washes, cells were stained with anti-CPS1-HRP antibody (Abcam 
#198969, 1:300, detailed description below, 45 minutes), and samples were analyzed on a 
FacsCalibur machine courtesy of Dr. Whitmire’s lab. For LCMV infections, VL4 antibody 
(BioXCell, BE0106) was conjugated to AF647 in the Whitmire lab. 
CPS1 antibody 
Anti-CPS1-HRP antibody was obtained from Abcam (#198969, 1:300) and is an 
intracellular marker (thus requires fixation and permeablization prior to antibody use). HRP-
conjugated antibodies can be used with tyramide signal amplication techniques to generate a 
fluorescent signal detectable by flow cytometry and immunofluorescence. AlexaFluor 488 signal 
was generated using the Thermofischer kit #T20922, and cells or tissues were incubated with the 
solution for 10 minutes before stopping the reaction and washing. Endogenous peroxidase signal 
was blocked with 0.3% hydrogen peroxide for 60 minutes prior to incubation with anti-CPS1 
antibody. 
 
 
61 
Immunofluorescence 
One lobe of the liver was perfused via the portal vein with 2% paraformaldehyde (PFA) 
in PBS and left to fix in 5 ml of 2% PFA overnight. The next day, the lobes were rinsed once in 
PBS and then placed in 5 ml of 30% sucrose in PBS for 2 days. The lobes were then placed in 
individual sectioning cassettes and frozen in OCT media on dry ice and stored at -80oC until 
sectioned. A cryotome machine was used to cut 0.5 µm sections. Tissues were brought to room 
temperature and fixed/permeabilized in cold acetone at 4oC for 20 minutes, rehydrated in PBS 
for 1 hour, and Fc-blocked with anti-CD16/CD32 in 1% BSA PBS for 1 hour. They were then 
stained overnight at 4oC with an antibody specific for the cleaved form of caspase-7 (Cell 
Signaling #9491, 1:500). The following day, slides were washed 3x for 5 minutes in PBS and 
stained with an APC-conjugated secondary anti-rabbit antibody (Cell Signaling, 1:1000) for 2 
hours. They were then stained with CPS1 as described above or a polyclonal anti-Listeria 
antibody (Abcam #68592, 1:10) for 1 hour. Mounting media contained DAPI.  
Quantification of signal by immunofluorescence 
Regions of interest (ROI) were drawn around lesions/inflammatory foci using the DAPI 
channel as a guide in ImageJ. The ROI was copied to the single channel image with cleaved 
caspase-7 and the integrated density was measured. Background integrated density (defined as 
the signal in an area outside the lesions/inflammatory foci) was subtracted for the reported values 
in Figures 3.3 and 3.8.   
Viral titer enumeration 
LCMV viral titer in the liver was quantified by plaque assay on Vero cell monolayers (40). 
MCMV viral titer in the liver was quantified by TCID50 assay on 10.1 murine embryonic 
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fibroblasts (MEFs). MEFs were seeded at 5000 cells/well into 96 well plates and allowed to 
adhere for 24 hours. Serial dilutions of liver homogenate was then added and cultured for 6 days 
before determining cytopathic effects (CPE). Titer was determined via the Reed Muench method.  
Statistics 
Error bars represent the standard deviation of technical replicates. A Mann-Whitney two-tailed t-
test (Prism 5; GraphPad) was used for statistical analysis, wherein P values of ≤ 0.05 were 
considered significant.  
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FIGURES  
 
 
 
Figure 3.1. Caspase-7 is downstream of NK perforin activity. Liver bacterial burdens were 
determined 3 days post infection for all panels and revealed an essential role for caspase-7 in 
defense. Mice were challenged with (a-d) 104 or (e) 100 C. violaceum and treated with IL-18 as 
indicated. f-g, Mice were adoptively transferred with 1x106 NK cells from the indicated sources 
and challenged with 104 Cv 24 hours later. Data pooled from two independent experiments for 
all. *P < 0.05 (Mann-Whitney U test). Bars indicate mean. 
 
Figure 3.2. Splenic defense functions independently of caspase-7. a, Ly5A+ splenocytes were 
harvested from wildtype mice and expanded ex vivo in IL-2 for the NK adoptive transfer 
experiments in Fig. 1. Shown is the percentage of transferred cells that were NK cells. 
Representative of 3 experiments. b-g, Splenic burdens from the infections performed in Fig. 3.1 
indicate that Casp7–/– mice do not have increased susceptibility to C. violaceum. 
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Figure 3.3. IL-18 drives NK activation of caspase-7. a-f, Immunofluorescence of Cv–infected 
livers to evaluate cleaved caspase-7 expression within lesions. Casp1–/–Casp11–/– mice were 
infected with 104 Cv, treated with PBS or IL-18, and harvested 2 days post infection. a-b, 
Representative images of livers stained with DAPI (blue), cleaved caspase-7 Ab (green), and the 
hepatocyte marker CPS1 (red). c-f Single channel and overlay images at higher magnification. a-
f, Scale bars, 50 µm. g, Cleaved caspase-7 signal was quantified from 2 lesions per mouse, with 
each dot as the average per mouse. Quantification was performed via ImageJ integrated density 
measurement. h, Percent of cleaved caspase-7 signal within CPS1 positive cells (200 cleaved 
caspase-7 cells were analyzed). i-k Mice were challenged with L. monocytogenes and treated 
with combinations of NK depleting antibody, isotype antibody, and IL-18 as indicated. Data 
pooled from two experiments for all panels. *P < 0.01 (Mann-Whitney U test). Bars indicate 
mean. 
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Figure 3.4. Caspase-7 is downstream of CTL perforin activity during Lm infection. a, 
Timeline for adoptive transfers during L. monocytogenes (Lm) infections. b-e, Mice were treated 
as outlined in (a), revealing that caspase-7 was required in the recipients and perforin was 
required in the donor cells for Lm liver defense post transfer. Data pooled from two independent 
experiments. *P < 0.05 (Mann-Whitney U test). Bars indicate mean.  
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Figure 3.5. CTL transfer mediates splenic defense independent of caspase-7. We examined 
the efficacy of adoptive transfers in defense against L. monocytogenes infection. a-b, Donor mice 
were NK depleted (> 99% eliminated) and their CTLs enriched by negative selection (> 72% 
purity). Mice were adoptively transferred with the indicated numbers of purified CTLs (naïve 
were given 1x107 as the maximum transferred number) and bacterial burdens were analyzed in 
the (c) liver and (d) spleen 3 days post infection. e-f, We found that the efficacy of bulk 
splenocyte transfer (5x107) with NK depletion was comparable to that of isolated CTLs, enabling 
us to minimize cellular manipulation. Bulk splenocyte transfers were used in Figure 3.4, 3.6, and 
3.8. Representative experiments. *P < 0.05 (Mann-Whitney U test). Bars indicate mean. 
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Figure 3.6. CTL transfer mediates splenic defense independent of caspase-7. a-d, Splenic 
burdens from the infections performed in Fig. 3 revealed that caspase-7 was not required for 
splenic defense against L. monocytogenes. Data pooled from two independent experiments (d-g). 
*P < 0.05 (Mann-Whitney U test). Bars indicate mean. 
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Figure 3.7. Listeria monocytogenes invades hepatocytes in vivo. a, Percentage of bacterial 
burden localized to hepatocytes 3 days post infection. Equal weight liver sections were removed 
and the hepatocyte fraction was graphed as a percentage of the total burden by weight. We can 
estimate the possible number of infected hepatocytes based on the maximum burdens per gram 
of liver at this time point (approximately 1x106) and the estimated number of hepatocytes per 
gram of liver (approximately 118x106) [REF(41)]. Thus, approximately 0.847% of hepatocytes 
could be infected with Lm, which within range of the cleaved caspase-7 positive hepatocytes 
observed in Fig. 4b. b, Example of VL4 staining in hepatocytes (CD45.2–CPS1+) harvested from 
WT and Prf1–/– mice 8 days post infection.  
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Figure 3.8. CTL perforin activity results in cleaved caspase-7 and efferocytosis. a, Timeline 
for adoptive transfers during Lm infections. b, Flow cytometry on enriched hepatocytes for 
cleaved caspase-7 staining and quantification. c-d Livers from mice infected and transferred as 
described in (a) were stained with DAPI (blue), cleaved caspase-7 Ab (green), and the 
hepatocyte marker CPS1 (red). Scale bars, 50 µm. d (enlarged, right) Higher magnification 
images to visualize CPS1 and cleaved caspase-7 signal localization. e, Cleaved caspase-7 signal 
was quantified from 5 lesions per mouse, with each dot as the average per mouse. Quantification 
was performed as in Fig. 3.3g. f, Colocalization of cleaved caspase-7 positive cells (green) and 
Listeria (red). h-i, Viral protein (VL4) expression within hepatocytes and viral titers in the liver 8 days 
post infection with LCMV Armstrong. Data representative of 2 experiments. b-g, Data pooled from 
2 experiments. *P < 0.01 (Mann-Whitney U test). Bars indicate mean. 
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CHAPTER 4: DISCUSSION 
 
PART I – Inflammasomes Defend Against the Purple Death 
 
After publication of the data in Chapter 2, we sought to further investigate our posited 
hypothesis that inflammasomes are evolutionarily conserved to defend against environmental 
organisms, not the host-adapted pathogens that are frequently used as models. This manuscript 
and its implications for the inflammasome field are explored in the text from our review below.  
 
REASSESSING THE EVOLUTIONARY IMPORTANCE OF INFLAMMASOMES4  
Inflammasomes are evolutionarily maintained in vertebrates (1), although the repertoire 
may be expanded or contracted in various species. Inflammasomes are proposed to aid in defense 
against a variety of infections.  However, inflammasome activation can also drive septic shock, 
leading to death (2, 3).  This would exert a selective pressure to lose inflammasomes. With this 
in mind, does the current published evidence support a positive selective pressure that explains 
the maintenance of inflammasomes over evolutionary time?   
 
 
                                                           
4 This chapter contains a manuscript that previously appeared as an article in The Journal of 
Immunology. I generated the data for the Table and co-wrote the manuscript with Dr. Miao. This 
is the author's version of the work. The definitive version was published in The Journal of 
Immunology 196 (3) doi: 10.4049/jimmunol.1502060. The full citation is: Maltez, V.I. and Miao, 
E.A., “Reassessing the evolutionary importance of inflammasomes.” JI 196 (3) pp. 956-962. 
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In vivo data suggests that inflammasomes delay, but do not eradicate infection 
In considering the positive selective pressure to maintain inflammasomes in defense 
against infection, many infectious studies have been performed using knockout mice, typically 
on the C57BL/6 background. Although inflammasome-deficient mice have increased 
susceptibility to many pathogens, the effect of inflammasomes on experimental survival studies 
is typically incremental. Salmonella enterica serovar Typhimurium (S. typhimurium) was one of 
the best and earliest examples. S. typhimurium replicates somewhat faster in Casp1–/–Casp11–/– 
mice, resulting in significantly increased burdens at any given time point post infection; for 
example at day 5 post infection, Casp1–/–Casp11–/– mice have 10 fold higher burdens than wild 
type (WT) mice (4). This translates into the WT mice surviving two days longer than the Casp1–
/–Casp11–/– mice (5), however it is important to remember that the WT mice still succumb, and 
thus the ultimate outcome of the infection remained unchanged. Our interpretation of these 
results is that inflammasomes alone cannot eradicate S. typhimurium, but merely slow its 
kinetics, which could be beneficial in that the animal may survive long enough to develop an 
adaptive immune response. In further support of this hypothesis, mice infected with Listeria 
monocytogenes that survive to days 7-8 post infection are able to mount a cytotoxic T 
lymphocyte (CTL) response that will combat and clear the infection. It is well established that 
this CTL response will eliminate L. monocytogenes (6). Therefore, slowing the course of 
infection could be the positive selective pressure that maintains inflammasomes over 
evolutionary time. 
Conversely, some infectious studies would, at first glance, suggest that inflammasomes 
have a critical role in defense. For example, we published that B. pseudomallei is lethal in 
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Casp1–/–Casp11–/– mice, while WT mice survive the infection (7). On its surface, such a result 
seems to have incredible power, leading to the interpretation that inflammasomes fully prevent 
lethal infection. However, interpretation of this result is confounded by the fact that we chose the 
dose specifically because it was not lethal in WT mice; in other words, we defined the dose as 
being sublethal. When a deeper analysis of the dose response is performed, the results lead to a 
more nuanced interpretation. In this regard, Fabio Re's group examined three doses of B. 
pseudomallei infection. They demonstrated that as few as 25 CFU resulted in 100% lethality in 
Casp1–/–Casp11–/– mice, whereas all the WT mice survive, consistent with our results.  However, 
when Re’s group increased the dose, they found that 100 CFU caused an intermediate lethality in 
WT mice, and 200 CFU was sufficient to cause 100% lethality in WT mice (8). Therefore, 
inflammasome detection of B. pseudomallei resulted in approximately an 8-fold shift in the lethal 
infectious dose. While this is not an insignificant degree of protection, the general conclusion 
could be that both WT and Casp1–/–Casp11–/– mice succumb to extremely low dose B. 
pseudomallei challenge. Thus, our interpretation is that although experiments performed at doses 
just under the lethal dose can appear fully penetrant, they may actually reflect a more subtle 
phenotype. 
We next considered whether this interpretation is consistent with other published data in 
infectious models. In contrast to Re’s work (8), most studies only use one infectious dose. 
Although this limits our ability to precisely evaluate the shift in lethal dose, we can estimate the 
minimum change supported by the data (rubric is described in Table 1 legend). As we wished to 
contrast various infectious models, we realized the difficulty of comparing pathogen burdens, 
pathology, or cytokine responses at various time points. On the other hand, the lethal challenge 
provides the same readout (survival) for an array of pathogens, routes, and doses; the survival 
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assay also integrates temporal effects. We therefore attempted to identify and collate all lethal 
challenge studies that have been performed in inflammasome knockout mice in order to illustrate 
the relative importance of inflammasomes in defense against numerous pathogens (Table 1). 
Unless otherwise indicated (Table 1, Notes column), all KO mice in Table 1 are Casp1–/–
Casp11–/– mice. It should be noted that while many survival studies have been performed with 
bacteria, fewer have been published with viral, fungal, and parasitic infection (further discussed 
below) (9-12). After collation of published survival studies (Table 1), it was striking that most 
changes in lethal dose were estimated to be in the 1-5 fold range. 
Therefore, the combined results of all infection survival studies in inflammasome-
deficient mice supports our interpretation that inflammasomes delay the course of infection, but 
do not have a dominant role in defense. Conversely, what if inflammasomes could provide rapid 
and potent defense against infection?  This would exert a strong selective pressure for pathogens 
to evolve inflammasome evasion strategies, minimizing the utility of inflammasomes. The 
difference between these two interpretations has a profound influence on how we think about the 
importance of inflammasomes. 
 
Vertebrate adapted pathogens evade inflammasomes 
Indeed, many pathogens evade inflammasome detection. For example, S. typhimurium 
induces rapid and profound caspase-1 activation in vitro. However, S. typhimurium encodes two 
T3SSs (SPI-1 and SPI-2), of which only SPI-1 is detected by NLRC4. Therefore, upon host cell 
entry and during the systemic phase of infection in vivo, S. typhimurium suppresses SPI-1 
expression in favor of the “silent” SPI-2 system. Further, S. typhimurium represses flagellin 
expression (13). The significance of these strategies in vivo cannot be understated, since S. 
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typhimurium engineered to express flagellin or SPI1 rod protein during systemic infection are 
completely attenuated in WT mice but fully virulent in inflammasome-deficient mice (14, 15). L. 
monocytogenes also represses flagellin, and is attenuated when engineered to persistently express 
it (16, 17). By virtue of being a Gram-positive bacterium, L. monocytogenes also naturally 
evades caspase-11, simply because it lacks LPS.  On the other hand, cytosol-invasive Francisella 
species have evolved to actively modify their LPS structure to evade caspase-11 detection (3).  
Another mechanism to evade cytosolic LPS detection by caspase-11 is by replicating in the 
vacuole, as is the case with numerous vacuolar pathogens, including S. typhimurium (7). 
In contrast, Yersinia species encode the effector YopM, which is capable of inhibiting 
caspase-1 by directly binding to the active site. This is critically important in vivo, as Y. 
pseudotuberculosis yopM mutants are attenuated in WT mice, but retain full virulence in Casp1–
/–Casp11–/– mice (18). Similarly, Shigella flexneri encode the OspC3 T3SS effector that inhibits 
human caspase-4 (19), thus preventing detection of its LPS as the bacterium invades the cytosol. 
Direct inhibition of inflammasome components is not limited to bacteria. Indeed, poxviruses 
encode crmA, a serpin that can inhibit several caspases (both inflammatory and apoptotic) and 
was identified as a caspase-1 inhibitor before the discovery of pyroptosis (20). Further, Kaposi’s 
sarcoma-associated herpesvirus (KSHV) encodes an NLR analog (the tegument protein Orf63) 
that inhibits NLRP1 and NLRP3 activation of caspase-1 (21).  
Another possible strategy for pathogens to cope with inflammasomes is to avoid the 
consequences downstream of inflammasome detection.  B. pseudomallei may be an example of 
this strategy by resisting the neutrophil killing (22) that occurs after the bacteria are ejected into 
the extracellular space by pyroptosis (14). Staphylococcus aureus may be another example, as 
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they are highly resistant to killing by neutrophils and have numerous toxins that inhibit 
neutrophil chemotaxis (23).   
These pathogens are striking examples that demonstrate the importance of evading 
inflammasome detection (Figure 1).  They show that inflammasomes could provide extremely 
potent defense against infection in vivo, but fail to do so because many pathogens minimize 
detection. 
 
Inflammasomes defend against opportunistic pathogens  
Vertebrate-adapted pathogens have evolved in the context of selective pressure exerted 
by the host immune system, and have accordingly potent virulence traits. In contrast, for 
opportunistic pathogens where humans are dead-end accidental hosts, there is no selective 
pressure to evade the human immune response.  However, such microbes could also encode an 
impressive array of virulence factors, which can enable extreme pathogenicity. For example, B. 
thailandensis encodes cytosol-invasive T3SS, but almost never causes infection in people (24).  
As such, it has been used as an experimental surrogate for its close relative B. pseudomallei (a 
BSL3 pathogen); in this capacity, our laboratory has studied B. thailandensis infection in vivo in 
mice.  
Shockingly, during systemic infection with B. thailandensis there is a 1,000,000-fold 
change between Casp1–/–Casp11–/– and WT mice (Table 1). The resistance conferred by 
inflammasomes is extremely efficient; WT mice fully sterilize even high dose B. thailandensis 
infection (2x107 CFU) within just one day (24). Clearly, inflammasomes can provide potent 
protection when presented with this specific pathogen. The strength of this phenotype was 
extremely surprising, rivaled only by the effect of inflammasomes upon pathogens that were 
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engineered to remove inflammasome evasion strategies. This made us re-evaluate the nature of 
B. thailandensis; we had simplistically considered it to be a surrogate for B. pseudomallei.  
However, it is important to keep in mind that B. thailandensis occupies a specific environmental 
niche as a soil microbe, where its T3SS is presumably used to invade the cytosol of an unknown 
eukaryotic host (25).  
Is B. thailandensis an isolated unique case? With these thoughts in mind, we began to 
screen for other environmental opportunistic pathogens that primarily cause disease in 
immunocompromised individuals, hypothesizing that healthy individuals would competently 
clear them via the activity of inflammasomes. In this endeavor, we discovered another ubiquitous 
environmental opportunistic pathogen against which inflammasomes play a similarly striking 
role, conferring a greater than 50,000 fold shift in the lethal dose (Table 1). Chromobacterium 
violaceum is a Gram-negative bacterium that lives in the sediment of fresh-water rivers and 
lakes. Although C. violaceum encodes two T3SSs that are similar to Salmonella SPI-1 and SPI-2 
and can be detected by NLRC4 (26), it virtually never causes disease in immunocompetent 
people (27). A confounding factor in the identification of these examples is that there may be 
redundant host defense pathways that independently confer sterilizing innate immunity. Indeed, 
it is quite surprising that defense against C. violaceum and B. thailandensis is mono-allellic. 
However, our studies with C. violaceum did reveal that pyroptosis is partially redundant with 
natural killer (NK) cell cytotoxicity, although both are dependent on caspase-1 activation (24). 
Further, if an opportunistic pathogen does not kill the host within one week, the adaptive 
immune response could compensate for the loss of inflammasomes. 
 
Specific virulence traits are required for inflammasome detection and defense 
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As evidenced by the vertebrate-adapted column in Table 1, several opportunistic 
pathogens have been examined in Casp1–/–Casp11–/– mice, yet none have demonstrated such 
large changes in the lethal dose as seen with C. violaceum and B. thailandensis. C. violaceum 
encodes two T3SSs (28), and concomitantly, defense is conferred by NLRC4 in vivo 
{Maltez:2015kt}. B. thailandensis invades the host cytosol, and its LPS is detected by caspase-
11 (7, 24), which confers defense in vivo. In both cases, it is the specific virulence traits that are 
detected by the inflammasomes. The evasion strategies employed by vertebrate-adapted 
pathogens are likely not present in these environmental bacteria, as they did not evolve in the 
presence of potential inflammasome detection. For example, both Klebsiella pneumoniae and 
Vibrio vulnificus are opportunistic pathogens that typically cause disease in 
immunocompromised patients (29, 30), which fits our model that healthy individuals would be 
protected by inflammasomes. However, neither has a strong in vivo phenotype in 
inflammasome-deficient mice (Table 1). Additionally, neither encode a T3SS nor are cytosol-
invasive, as is the case for B. thailandensis and C. violaceum. Thus, they may lack 
inflammasome agonists.  
 
Hypothesis  
The predominance of evidence suggests that vertebrate-adapted pathogens have evolved 
to minimize the effectiveness of inflammasomes; in vivo phenotypes are typically incremental, 
and evasion strategies are prevalent.  Why, then, are inflammasomes maintained in the human 
genome? The extreme virulence of B. thailandensis and C. violaceum in inflammasome-deficient 
mice leads us to propose a new hypothesis regarding the importance of inflammasomes in the 
immune system. We hypothesize that inflammasomes defend against ubiquitous environmental 
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microbes with specific virulence traits.  Further, we propose that inflammasome-directed defense 
is so efficient that the infection never progresses to clinically apparent symptoms. It is interesting 
to note that inflammasome-deficient patients have not been identified.  We speculate that a 
survey of apparently immunocompetent people with susceptibility to specific opportunistic 
pathogens, such as C. violaceum, could identify patients with inflammasome mutations.  For 
example, in a case series of 106 C. violaceum infections, only 15 percent were directly attributed 
to an immunocompromising comorbidity (such as chronic granulomatous disease) (27).   
 
Caveats to the hypothesis 
There are several caveats that temper interpretation of the extreme virulence of B. 
thailandensis and C. violaceum in Casp1–/–Casp11–/– mice. One consideration is that Casp1–/–
Casp11–/– animals are inbred and typically maintained on a C57BL/6 background that naturally 
lacks NRAMP1 (31). Mice lacking NRAMP1 have increased susceptibility to numerous 
intracellular pathogens, including S. typhimurium, L. monocytogenes, and Mycobacterium 
tuberculosis. This caveat has not gone unnoticed. In 2006, Lara-Tejero et al investigated the 
roles of inflammasomes in Nramp1-sufficient mice during S. typhimurium infection. However, 
regardless of the presence of a functional Nramp1 gene, Casp1–/–Casp11–/– mice still showed an 
incremental susceptibility to S. typhimurium infection in comparison to their WT counterparts 
(4).  
Further, 129/SvEv mice are Nramp1-sufficient, but carry a spontaneous mutation in 
caspase-11 (32). Aachoui et al infected 129/SvEv (Casp11–/–Nramp1+/+) mice and found that 
they have extreme susceptibility to B. thailandensis that is comparable to C57BL/6 Casp11–/– 
(Nramp1–/–) mice, whereas BALB/c (Casp11+/+Nramp1–/–) remained resistant (24). Thus, the 
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potency of inflammasome defense against this environmental bacterium was not significantly 
altered by the presence or absence of Nramp1. 
In addition to the influence of Nramp1 on different inbred mouse strains, there is also the 
fact that mice are not men; while this may seem to be an obvious caveat, it is one worth 
expanding upon. There are species barriers that can influence the virulence of pathogens. There 
are several examples of bacteria (Shigella spp, Salmonella typhi) that fail to establish mouse 
infections despite infectivity in humans. However, there are far more examples of viruses that 
have human-specific strains that do not infect mice: human cytomegalovirus, HIV, HBV, HCV, 
Epstein-Barr virus, measles, mumps, and many more (33). Therefore, there could be more 
stringent non-inflammasome barriers restricting interspecies dissemination of viruses in 
comparison to bacteria.  Therefore, our hypothesis that inflammasomes defend against 
environmental microbes might not hold true for viruses.  
Certain inflammasomes, but not all, are conserved between mice and humans. NLRC4, 
NLRP3, caspase-1, and AIM2 are highly conserved over evolutionary time, from sharks to 
humans (Maltez and Miao BLAST searches). Yet, despite the high conservation of the ALR 
family member AIM2, there are 12 additional ALRs in mice but only 3 more in humans, 
suggesting active evolution of this gene family (34). Because AIM2/ALRs are often attributed to 
recognizing viral infections, the diversity within this family over evolutionary time could argue 
against the hypothesis that they defend against specific environmental pathogens. Similarly, mice 
encode three NLRP1 genes that are highly polymorphic between inbred mouse strains, and there 
is only one human NLRP1 (35). This again suggests active evolution of the NLRP1 locus. Thus, 
our hypothesis might only hold true for certain highly conserved inflammasomes, and not for the 
more divergent or polymorphic inflammasomes. 
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Conclusion 
If vertebrate-adapted pathogens minimize the effectiveness of inflammasomes, why 
should we continue to study them? First, even sub-optimal inflammasome responses may have 
clinically beneficial effects during infection by vertebrate-adapted pathogens. Second, 
inflammasomes seem to be important drivers of the pathology of severe sepsis and septic shock 
(2, 3, 36). There are no immunologically directed therapies for sepsis; supportive treatments are 
useful, but nevertheless 28% of patients with sepsis die. Study of the downstream effect(s) of 
aberrant inflammasome activation could aid in the development of new directed treatments.  
If vertebrate-adapted pathogens minimize the effectiveness of inflammasomes, how 
should we best study them? Opportunistic pathogens have the potential to lead us to novel 
insights and to reveal therapeutic approaches. Our work with C. violaceum demonstrates the 
reality of this potential – we discovered a novel link between inflammasome activation and in 
vivo perforin-mediated defense that was then applicable to L. monocytogenes infection as a 
cytokine therapy. With the rise in antibiotic-resistant microbes, there is a pressing need for new 
immunotherapeutic approaches to treat infection. 
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 Table I. Inflammasome survival studies reveal incremental inflammasome protection. 
Pathogen Vert.   Time to death % Survival Δ lethal    
 Adapted Dose Route WT KO  WT KO dose
*
 Notes Ref 
BACTERIA           
Bacillus anthracis  Y 105 sc ∞ 80 h 100% 0% >5 † (1) 
Bacillus anthracis Ames  Y 4x102 ip 3 d 3 d 50% 25% >1 ‡ (2) 
Bacillus anthracis Sterne Y 2.5x107 ip ∞ 4 d 100% 0% >5 ‡ (2) 
Burkholderia cepacia N 106 ip ∞ ∞ 100% 100% 1  X 
Burkholderia pseudomallei Y 200 in 4 d n.d. 0% n.d.  
>8 
 (3) 
  100 in 4 d 4 d 65% 0%  (3) 
  25 in ∞ 4 d 100% 0%  (3) 
  100 in ∞ 2-3 d 100% 0% >5  (4) 
  100 in ∞ 3.5 d 100% 0% >5  (5) 
Burkholderia thailandensis N 2x107 ip ∞ 1 d 100% 0%  
 
>1,000,000 
 (6) 
  106 ip ∞ 2 d 100% 0%  (6) 
  105 ip ∞ 2 d 100% 0%  (6) 
  104 ip ∞ 2 d 100% 0%  (6) 
  1000 ip ∞ 3 d 100% 0%  (6) 
  100 ip ∞ 3 d 100% 0%  (6) 
Chromobacterium violaceum N 106 ip ∞ n.d. 100% n.d.  
>50,000 
 X 
  104 ip ∞ 3 d 100% 0%  X 
  100 Ip ∞ 4 d 100% 0%  X 
Francisella tularensis subsp. novicida Y 1.5x105 sc 4 d 3 d 65% 0% >2 # (7) 
  1.5x105 sc 6 d 4 d 25% 0% >1  (8) 
  5x103 sc 3 d 2.5 d 75% 0% >2  (9) 
Francisella philomiragia N 106 ip ∞ ∞ 100% 100% 1  X 
Klebsiella pneumoniae N 7.4x104 it 50 h 45 h  15% 0% >1 # (10) 
  1000 in 5 d 5 d 75% 40% >1  (11) 
  104 in 4 d 6 d 50% 15% >1  (11) 
Listeria monocytogenes Y 106 iv 5 d 3-4 d 35-65% 0% >2  (12) 
Mycobacterium tuberculosis Y 250-350 in 200 d 148 d  0% 0% 1 # (13) 
  250-350 in 170 d 170 d  0% 0% 1  (13) 
  50-100  in 200 d 110 d 90% 0% >2  (14) 
  106 it ∞ 6 d  0% 0% >5 # (15) 
Pseudomonas aeruginosa N 2x107 in 36 h 40 h  20% 65% >1 # (16) 
  7x105 it 3 d ∞ 10% 0% 1 # (17) 
Salmonella enterica serovar Typhimurium Y 100 ip 5 d 5 d 0% 0% 1  (18) 
  106 oral 9 d 6 d 0% 0% 1  (19) 
  108 oral 8 d 5.5 d 0% 0% 1  (20) 
Shigella flexneri Y 2x108 in 20 h 45 h 75% 20% >2  (21) 
Staphylococcus aureus Y 1x104 ic 20 h 18 h 60% 25% >1  (22) 
Streptococcus agalactiae (Group B) Y 105 ip ∞ 24 h 100% 40% >2  (23) 
Streptococcus pneumoniae Y 105 In 3 d 2.5 d 87% 55% >1  (24) 
Vibrio vulnificus N 1.5x104 ip ∞ 24 h 100% 60% >1  (25) 
Yersinia pestis Y 1x104 in 72 h 72 h 0% 0% 1  (26) 
Yersinia pseudotuberculosis Y 1000 ip 6 d 4 d 0% 0% 1  (27) 
  1x109 oral 7 d 6 d 0% 0% 1  (28) 
VIRUSES           
Encephalomyocarditis virus Y 2x LD50 ip 5 d 5 d 10% 15% >1  (29) 
Influenza A virus Y 6x104 in 8 d 7 d 65% 40% >1  (30) 
  8x103 in 11 d 10 d 65% 35% >1  (31) 
  10 in ∞ 11 d 100% 0% >5  (32) 
Vesicular stomatitis virus Y 2x105 in 7 d 7 d 40% 20% >1  (29) 
West Nile virus Y 100 sc 9 d 9 d 80% 50% >1  (33, 34) 
FUNGI           
Aspergillus fumigatus N 1x105 ip 6 d 4 d 70% 0% >2  (35) 
Candida albicans Y 105 iv 9 d 5 d  40% 0% >1 # (36) 
  2x105 iv 18 d 17 d 83% 50% >1  (37) 
  5x106 oral N/A 3 d  100% 60% >1 # (38) 
 
 
n.s. oral ∞ 5 d 97% 60% >1 
 {Hise:20
09db} 
Paracoccidioides brasiliensis N 2x106 iv 90 d 75 d 50% 0% >2  (39) 
PARASITES           
Plasmodium berghei Y 10 iv 9 d 10 d  40% 75% >1 # (40) 
Plasmodium berghei iRBCs Y 104 iv 6.5 d 6.5 d 0% 0% 1  (41) 
Plasmodium berghei sporozites Y 104 iv 6.5 d 6.5 d 0% 0% 1  (41) 
Plasmodium chabaudi adami Y 5x104 ip 11 d 12 d  0% 0% 1 # (42) 
Plasmodium falciparum Y 106 ip 6 d 6 d 0% 0% 1  (43) 
Toxoplasma gondii Y 104 ip 10 d 9 d 75% 10% >2  (44) 
Trypanosoma cruzi Y 103 ip 20 d 20 d 70% 10% >2  (45) 
  103 sc 22 d 28 d 80% 90% >1  (46) 
 
* Change in 100% lethality between WT and KO mice. Values based on reference 3 because difference was 8 fold between WT 100% lethality and lowest dose listed. 
However, since there was no dose where Casp1–/–Casp11–/– mice did not die, the difference was listed as >8 fold. Thus, a difference in survival percentages of <50% 
was estimated to be >1 fold increase in the infectious dose, >50% was estimated to be >2 fold, and >100% was estimated to be >5 fold.  
†Mice encoding NLRP1b that could detect anthrax lethal toxin, leading to caspase-1 activation and cytokine secretion. KO mice have this sensitive NLRP1b but lack 
caspase-1 and -11. 
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PART II – Unique Roles for Caspase-7 in Bacterial Defense  
 
 
The work described in Chapter 3 tackled the role of caspase-7 in defense against liver 
pathogens. Caspase-7 has been mostly ignored in the field since previous studies have found 
limited or conflicting roles for caspase-7 in vivo (38-40). In contrast, our work demonstrates a 
clear and specific role for caspase-7 that is both independent of caspase-1 and cannot be 
compensated for with caspase-3. We found that NK defense required caspase-7 against C. 
violaceum, but not the viral NK model MCMV. Analogously, CTL defense required caspase-7 
against L. monocytogenes, but not the viral CTL model LCMV. This led us to propose a 
paradigm for caspase-7 in pathogenic defense against bacteria, but not viruses. There are, 
however, several mechanistic questions that remain unanswered and could be addressed in future 
studies. 
 
Caspase-7 has unique cellular substrates 
As mentioned in Chapter 3, much of the literature surrounding caspase-7 has examined 
its molecular substrates and whether they are unique compared to caspase-3 (41-43). Caspase-7 
has a select few preferential substrates, of which focal adhesion kinase (FAK) is the most likely 
candidate, FAK is 100X more sensitive to cleavage by caspase-7 than any other caspase (44). 
FAK is tyrosine kinase that is required to break the focal adhesions between cells and 
extracellular matrix, so it’s activation is often thought of in terms of cellular migration (44). 
However, we hypothesize that FAK cleavage by caspase-7 would be beneficial in our infectious 
models because it would enable cell detachment, something that has been posited previously 
(42). Additionally, we believe we are indeed observing cell detachment in cleaved caspase-7 
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positive cells by immunofluorescence (Chapter 3, IF images), as the cells have gaps between 
them but do not look canonically apoptotic. 
 
Efferocytosis 
In order to maintain tissue homeostasis, cellular debris must be efficiently removed. This 
need is addressed in the form of efferocytosis, whereby professional phagocytes (macrophages or 
neutrophils) engulf the debris and degrade it (45). Accordingly, efferocytosis is highly regulated, 
involving a well described compendium of “eat me” signals to guide phagocytes to the debris. 
Efferocytosis has primarily been studied in the context of apoptotic bodies/debris, of which 
macrophages are the primary efferocytic phagocyte (45).  
 Interestingly, a previous lab member, Ine Jorgenson, found that bacteria survive both 
apoptosis and pyroptosis (46); viruses do not, which could account for the dispensability of 
caspase-7 against the viruses we examined. In fact, she found that pyroptosis triggered pore-
induced intracellular traps (PITs) that ensnared live bacteria in the cell corpse. These bacteria 
remained viable until the cell corpse was efferocytosed by neutrophils, which killed the bacteria 
in a ROS-dependent manner (46). Although we do not know precisely how hepatocytes die 
during C. violaceum or L. monocytogenes infection, it is conceivable that cellular detachment via 
FAK would be an advantageous upstream step to enhance efferocytosis.  
In fact, we have preliminary data to suggest that efferocytosis is enhanced by caspase-7 
cleavage during L. monocytogenes infection (Fig. 4.1). The percentage of neutrophils (CD45.2+ 
Ly6G+) containing hepatocytes (CPS1) is markedly increased when mice were adoptively 
transferred with CTLs from immunized mice (as done in Chapter 3, Figure 3.8). Future work into 
the role of caspase-7 in efferocytosis will include use of the Amnis ImageStream, a technique 
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whereby an image is taken of each cell as it passes 
through the flow cell. This machine could be used 
to visualize infected (Listeria antibody), cleaved 
caspase-7 positive efferocytosed hepatocytes 
within neutrophils.  
 
Cell-to-cell spread 
 In addition to, or instead of, aiding in 
efferocytosis, caspase-7 activation could primarily 
inhibit cell-to-cell spread by pathogens. In order to 
avoid the myriad of extracellular immune defenses, 
many pathogens hop from cell to cell, either by tight junctions or by forcing protrusions that are 
internalized by the neighboring cell (47). Thus, detaching infected cells from their neighbors 
could severely hinder this pathogenic mechanism.  
Although we do not know how C. violaceum spreads, we do know that L. monocytogenes 
uses actin rockets to rapidly spread between cells. In this case, FAK activation by caspase-7 
could doubly impact L. monocytogenes by removing cell contacts and crippling these actin 
rockets. This could be tested in vitro by live cell imaging using fluorophore-labeled actin and L. 
monocytogenes. Hepatocytes could be infected with our GFP-L. monocytogenes strain and 
cocultured with immunized CTLs. We could then monitor actin rocket formation as a timecourse 
during coincubation. At various points the cells could be fixed and stained for cleaved caspase-7 
to evaluate whether the disruption of actin rockets correlated with caspase-7 activation.  
 
Figure 4.1. Efferocytosis of hepatocytes by 
neutrophils correlates with increased cleaved 
caspase-7. Percent of hepatocytes in neutrophils 
and the mean fluorescence intensity of cleaved 
caspase-7 signal within those efferocytosed 
hepatocytes is increased upon immunized CTL 
transfer during L. monocytogenes infection. 
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Natural killer cell and cytotoxic T lymphocyte cytotoxicity 
 Our work in Chapter 3 illustrates the importance of cell-extrinsic activation of caspase-7 
in bacterial defense. Both NK cells and CTLs canonically induce apoptosis in target cells via 
granzyme B activation of caspase-3 (48, 49), but our work challenges this as the sole means of 
achieving target cell death. Although we did not mechanistically show that granzyme B activates 
caspase-7 in our model, we hypothesize this is the most likely activator since granzyme B has a 
higher affinity for caspase-7 than -3 (50). In order to examine this in the future, we obtained 
purified granzyme B protein, which can be introduced into cells via non-covalent peptide 
transduction (51). We could examine the effects of granzyme B on caspase-7 in isolated 
hepatocytes by Western blot or antibody staining, and simultaneously visualize possible cell 
detachment. In this case, we would also compare cell detachment between wildtype and Casp7–/– 
hepatocytes. These experiments would inform both the upstream activation of caspase-7 and the 
downstream effects in hepatocytes.  
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